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Abstract 
 
Septic shock is characterized by systemic vasodilatation and an attenuated 
pressor response to catecholamines. As the hyperactivity (i.e. more channels 
remain in the open state) of the vascular adenosine triphosphate (ATP)-
sensitive type of potassium (KATP) channels results in vasodilatation, this 
channel has been implicated in the pathogenesis of septic shock. The studies 
present in this thesis sought to demonstrate that sepsis activates vascular KATP 
channels, that channel inhibition reverses hypotension, and that channel 
hyperactivity is related to an increased gene expression. Rat aortic smooth 
muscle cells exposed to bacterial endotoxin and the inflammatory mediator 
interleukin-1β were found to have an increased gene expression of KIR6.1, the 
channel’s pore-forming subunit, at 48h. This gene induction could be reversed 
by the nitric oxide synthase inhibitor, 1400W. KIR6.1 mRNA was also increased 
in mesenteric arteries from rats subjected to faecal peritonitis for 24h. 
86Rubidium efflux experiments revealed an increased channel activity in these 
vessels when stimulated by the KATP-channel opener, levcromakalim; the basal 
activity, however, remained unchanged. Conscious rats subjected to faecal 
peritonitis developed an attenuated pressor response to norepinephrine that, 
unexpectedly, could not be reversed by the channel inhibitor, PNU-37883A; this 
agent could not either elevate the baseline blood pressure of septic rats. 
Surprisingly, this attenuated pressor response to PNU-37883A could be 
partially reversed by the autonomic ganglion blocker, pentolinium, suggesting 
that during sepsis the vascular KATP channel may be inhibited in vivo by the high 
sympathetic tone. Therefore, the inhibition of vascular KATP channels may 
assume a limited role in the treatment of septic shock. 
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Chapter One Introduction 
Chapter 1. Introduction 
 
Sepsis is the acute systemic inflammation induced by infection that can 
progress to multiple organ dysfunction (Bone et al., 1992). This dysfunction can 
include a decrease in vascular tone and the resultant persisting hypotension, 
“septic shock,” a condition that carries a high mortality. As hyperactivity (i.e., 
more channels remaining in the open state) of the potassium (K+) channel in the 
plasma membrane of arterial smooth muscle can cause vasodilatation (Nelson 
and Quayle, 1995), these channels, particularly the adenosine triphosphate 
(ATP)-sensitive type (KATP) of channels, are implicated in the pathogenesis of 
septic shock (Landry and Oliver, 1992). Since vascular KATP channel hyper-
activity may originate from an increase in channel number or/and channel open 
probability, the work presented in this thesis sought to understand if sepsis 
could induce the expression of the channel gene and a subsequent increase in 
the channel number. I also investigated the feasibility of inhibiting the channel to 
reverse the vasodilatation and vascular hyporeactivity induced by sepsis. 
 
1.1. Severe sepsis and septic shock: a major medical challenge 
Modern medicine uses the term ‘sepsis’ (Greek: σηψιζ, the decomposition of 
organic matter in the presence of bacteria) (Geroulanos and Douka, 2006) to 
denote the acute systemic inflammation that results from the massive and 
widespread activation of the immune system by microbial toxins and cell 
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components (Bone et al., 1992). As a host response aiming to eradicate the 
pathogen, sepsis is composed of a variety of acute immune reactions involving 
multiple components and mediators, including monocytes/macrophages, 
neutrophils, endothelium, cytokines, the complement system, coagulation 
cascades, lipid mediators, the nervous system, and adaptive immunity (for 
reviews, see Cohen, 2002; Annane et al., 2005). Responses are both pro-
inflammatory to enhance the antimicrobial activity, and concurrently anti-
inflammatory to prevent excessive and unfettered inflammation. However, when 
the pro-inflammatory reaction is excessively strong and uncontrolled by the 
balancing anti-inflammatory response, sepsis can progress and lead to 
deleterious consequences. 
 
Sepsis becomes dangerous to the host when acute organ dysfunction develops; 
this condition is termed ‘severe sepsis’ (Bone et al., 1992). This organ 
dysfunction frequently involves the lungs (acute lung injury or, more severely, 
the acute respiratory distress syndrome), the kidneys (acute renal failure), the 
coagulation system (disseminated intravascular coagulation), brain and nervous 
system (encephalopathy, neuropathy), muscle (myopathy) and the liver. Cardio-
vascular dysfunction can lead to tissue hypoperfusion and, in some cases, 
profound hypotension despite adequate fluid resuscitation (septic shock). When 
more than one organ systems develop dysfunction, the patient is said to have 
multiple organ dysfunction syndrome (MODS; Bone et al., 1992). 
 
Sepsis can induce numerous pathophysiological abnormalities that can cause 
organ dysfunction. These include tissue hypoperfusion (Bakker et al., 1996), 
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derangement of the microcirculation (De Backer et al., 2002), abnormal 
intravascular coagulation (Bernard et al., 2001), the induction of apoptosis 
(Hotchkiss et al., 1999), an increase in oxidative stress (Goode et al., 1995), 
and cellular bioenergetic failure (Brealey et al., 2004). Since this organ 
dysfunction often renders the body unable to maintain normal homeostasis, a 
third to half of severely septic patients eventually succumb to death, despite 
active medical intervention (Levy et al., 2010). 
 
The presence of septic shock is associated with the highest mortality rates, 
claiming 40-70% of affected victims (Annane et al., 2003). It can probably be 
considered the major cause of early death from sepsis (Rivers et al., 2001). 
This poor prognosis persists despite attempts to reverse the shock using fluid 
resuscitation and potent intravenous (i.v.) vasopressor agents such as norepi-
nephrine (NE) and dopamine. The degree to which this is related to the severity 
of the septic condition itself, or to covert harm from current therapies such as 
catecholamines (Singer, 2007) is a subject of increasing debate. 
 
1.2. Septic shock is a form of vasodilatory shock 
1.2.1. Arterial blood pressure and vascular tone 
The main role of the cardiovascular system is to transport oxygen and nutrients 
to the tissue and to remove waste products. Small arteries and arterioles have 
small diameters and thus high resistance to blood flow (Badeer, 2001). To 
overcome this resistance and drive blood flow through these vessels, the 
arterial pressure is maintained at high levels through the heart’s continual 
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pumping of blood into a tight arterial vasculature, wherein the low compliance 
generates high pressures from small filling volumes. The arterial vasculature 
has only a very narrow margin for maintaining adequate pressures volume-wise 
(Guyton and Hall, 2006). Underfilling of the vasculature as a result of a reduced 
blood volume (hypovolaemia) or/and a weakened cardiac pump can 
significantly lower arterial pressure. The volume deficit in question could be no 
more than a few hundred millilitres. 
 
Arteries are normally maintained in a partially constricted state, termed 
“vascular tone,” which determines the arterial blood pressure at a given cardiac 
output. In most tissues, the blood vessels (except metarterioles and capillaries) 
are innervated by sympathetic nerve fibres that transmit continual impulses 
from the brain stem vasomotor centre to the vessels. These impulses stimulate 
continual release of NE and other vasoactive substances (e.g. ATP) from 
sympathetic and other nerve endings to induce vascular smooth muscle 
contraction, through the adrenergic receptor-dependent and independent 
mechanisms (for review, see Hirst and Edwards, 1989). The frequency of neural 
impulses is termed “sympathetic tone.” More frequent impulses (higher 
sympathetic tone) stimulate release of more vasoactive substance to cause a 
greater degree of vascular smooth muscle contraction and vasoconstriction. 
Conversely, less frequent impulses (lower sympathetic tone) cause smooth 
muscle relaxation and vasodilatation.  
 
When hypotension develops, the body responds acutely by (i) ‘pressurizing’ 
arteries through constricting the vessel and pumping in more blood, and (ii) 
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increasing water reabsorption from the kidneys through an increase in 
hormones like vasopressin, angiotensin II and aldosterone. Although arterial 
constriction may decrease the blood flow through certain parts of the body and 
thereby cause tissue ischaemia and necrosis, without this constriction the tissue 
hypoperfusion resulting from hypotension will be even more profound and 
diffuse (Bonev and Nelson, 1993a). Therefore, rapid and potent haemodynamic 
homeostasis-maintaining mechanisms sense changes in arterial blood pressure, 
to which they respond aggressively.  
 
1.2.2. Vascular tone is decreased during septic shock 
Several mechanisms act in concert to reverse hypotension and maintain blood 
pressure (Figure 1.1; for review, see Guyton, 1991). Rapid-acting pressure 
controllers include the baroreceptor reflex, the chemoreceptor reflex, and the 
central nervous system ischaemic response. These controllers function through 
stimulating sympathetic tone, which constricts both the arterial and the venous 
vasculature and increases myocardial contractility. Hypotension also rapidly 
stimulates the production of angiotensin II and secretion of vasopressin; both 
are vasoactive hormones that also constrict arterioles. Arterial vasoconstriction 
elevates blood pressure, whereas venoconstriction increases cardiac preload. 
Arterial hypotension can also mobilize blood from a major reservoir of blood 
volume, the splanchnic veins, into the systemic circulation (Gelman, 2008). The 
increase in both myocardial contractility and cardiac preload augments cardiac 
output, which also helps to maintain an adequate arterial pressure. Hypo-
volaemia or impaired cardiac pumping usually induces an increased vascular 
 22 
 
Figure 1.1. Potency of major blood pressure-controlling mechanisms at different 
time intervals. Potency is shown in terms of feedback gain, the ratio between changes 
in blood pressure correctable by the specific mechanism and the final change in 
pressure that remains. The vertical dashed line indicates a sudden change in blood 
pressure. CNS = central nervous system. Figure reproduced from Guyton (1991) as 
adapted from Guyton, A. C. (1980): Arterial Pressure and Hypertension. Philadelphia, 
PA, USA: W. B. Saunders and Co. Figure reproduced with permission, copyright 1980, 
W. B. Saunders and Co. 
 
tone and vasoconstriction to maintain blood pressure. If these compensatory 
mechanisms are overwhelmed, blood pressure falls leading to hypovolaemic 
and cardiogenic shock, respectively. In contrast, septic shock can primarily be 
characterized by a systemic vasodilatation, i.e. the vascular tone is directly 
decreased. The vascular response to catecholamines (“vascular reactivity”) to 
therapeutically elevate the arterial pressure (a “pressor” effect) also becomes 
significantly attenuated. Septic shock is widely regarded as the prototype of 
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“vasodilatory” shock; other conditions include severe anaphylactoid reactions 
and spinal cord injury. The relative contributions of sepsis-induced vasodilating 
stimuli overwhelming blood pressure-maintaining mechanisms versus the 
degree of dysfunction of the compensatory mechanisms themselves requires 
further study. 
 
Aside from arterial vasodilatation, sepsis also induces other physiological 
changes that may contribute to the development of hypotension. These include 
an increase in vascular permeability, a prominent feature of systemic 
inflammation that leads to increased capillary leak of fluid and plasma proteins. 
This results in a decrease in intravascular volume and thus a fall in cardiac 
preload. Secondly, myocardial depression (Rudiger and Singer, 2007) may 
become the major haemodynamic abnormality in about 10% of septic shock 
patients. In addition, changes in the venous system (Jacobsohn et al., 1997), 
neural reflexes (Banet and Guyton, 1971), and adrenergic receptor number 
(Carcillo et al., 1988) or function (Sibley and Lefkowitz, 1985) may also 
contribute to the disease process. Their relative importance and respective 
effects remain to be clarified. 
 
1.3. How does sepsis affect vascular smooth muscle contractility? 
1.3.1. Vascular smooth muscle contraction and relaxation 
Vascular smooth muscle contraction is triggered by a rise in intracellular 
calcium (Ca2+) concentration ([Ca2+]i). Ca2+ then binds with calmodulin and the 
complex activates myosin light chain kinase to phosphorylate the myosin head, 
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thereby facilitating its repetitive binding to the actin filament; the subsequent 
attachment-detachment cycling between the two molecules causes smooth 
muscle contraction. [Ca2+]i is therefore an important determinant of the 
contractile status of vascular smooth muscle (Rembold and Murphy, 1988). The 
resting [Ca2+]i level in smooth muscle is ~0.1 µM. Smooth muscle contraction 
and vasoconstriction can be induced by an [Ca2+]i above ~1 µM, whereas a low 
[Ca2+]i ceases to activate the myosin light chain kinase and stops the 
contracting (shortening) process without relaxing the muscle. Complex 
mechanisms jointly regulate vascular smooth muscle [Ca2+]i (for reviews, see 
Akata, 2007b, 2007a). 
 
The relaxation of vascular smooth muscle depends on the activity of the 
enzyme, myosin phosphatase, which dephosphorylates the myosin head and 
thus interrupts its interaction with actins (for review, see Horowitz et al., 1996). 
An increased activity of myosin phosphatase can counteract that of the myosin 
light chain kinase, resulting in an attenuated muscle contraction for a given 
[Ca2+]i. This phenomenon is often described as the ‘desensitization’ of the 
contractile apparatus to Ca2+; this serves as another important mechanism to 
modulate smooth muscle contraction (for review, see Ratz et al., 2005). 
 
Major endogenous vasoconstricting stimuli include an elevated sympathetic 
tone and circulating hormones such as catecholamines, angiotensin II, and 
vasopressin. Elevated sympathetic tone not only increases the release of NE 
from sympathetic nerve endings, but also stimulates the adrenal medullae to 
secrete NE and epinephrine into the blood. This exerts almost the same effect 
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as direct sympathetic stimulation (Guyton and Hall, 2006). Angiotensin II and 
vasopressin are both potent arterial vasoconstrictors, but only angiotensin II can 
cause moderate venoconstriction (Lee et al., 1988). Importantly, these vaso-
pressors induce vascular smooth muscle contraction principally through a 
common intracellular signalling pathway: the activation of phospholipase C 
(PLC)-β by the Gq-protein that couples to their respective receptors in the cell 
membrane (for review, see Rhee, 2001). PLC-β, through the hydrolysis of the 
membrane phospholipid phosphatidylinositol 4,5-bisphosphate, generates two 
messengers, i.e., inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG), the 
latter going on to activate protein kinase C (PKC). IP3 elevates vascular smooth 
muscle [Ca2+]i principally through inducing the release of Ca2+ from the 
sarcoplasmic reticulum (SR); this accounts for the initial phasic component of 
contraction. At the same time, a sustained increase in [Ca2+]i can occur by the 
influx of extracellular Ca2+ down its electrochemical gradient, produced by the 
action of DAG and PKC on membrane ion channels. This involves activation of 
both the non-selective Ca2+-permeable cation channel, and the L-type voltage-
dependent Ca2+ channels (VDCC) by PKC (Nelson et al., 1990; Schöfl et al., 
1995; Barrett et al., 2007b). The activity of VDCC can be further enhanced as 
opening of cation channels will also cause cell membrane depolarization. 
 
There are also important endogenous vasodilators, such as prostacyclin, 
adenosine and calcitonin gene-related peptide (CGRP). These vasodilators act 
through binding to their respective receptors that couple to the Gs-protein that 
subsequently activates the enzyme, adenylate cyclase. This enzyme then 
synthesizes adenosine 3’,5’-cyclic monophosphate (cAMP) from ATP and 
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subsequently goes on to activate the cAMP-dependent protein kinase (PKA). 
PKA may phosphorylate myosin light chain kinase and thereby decrease its 
affinity to Ca2+, leading to a decrease in its activation (Rembold, 1992). PKA 
also lowers [Ca2+]i through (i) inhibiting Ca2+ entry from the extracellular milieu 
and Ca2+ release from intracellular stores; (ii) facilitating Ca2+ clearance from 
the cytosol; (iii) inhibiting the generation of IP3 (Murthy et al., 1993); and (iv) 
activating K+ channels (Clapp and Tinker, 1998; Ko et al., 2008). These 
vasodilators are often found to be elevated during sepsis (Bernard et al., 1991; 
Martin et al., 2000; Muller et al., 2001), but their contribution to the development 
of sepsis-induced vasodilatation is perhaps not as profound as that of nitric 
oxide (NO), another potent vasodilator important in the pathogenesis of septic 
shock (see 1.3.3). 
 
1.3.2. Voltage dependence of vascular tone 
Vascular tone is also dependent on the arterial smooth muscle membrane 
potential (Em), and this too may be altered during sepsis. The tonic component 
of smooth muscle contraction is induced by a tonic increase in [Ca2+]i, which 
itself is dependent on the activity of L-type VDCC that allows Ca2+ entry from 
the extracellular milieu (Orallo, 1996). The activity of the VDCC is largely 
dependent on the smooth muscle resting Em; this is normally about -40 to -60 
mV in vivo. At the physiological level of vascular smooth muscle Em there is a 
steep relationship between it and the corresponding VDCC activity: a change of 
3 mV can alter Ca2+ influx by as much as twofold (Nelson et al., 1990). Vascular 
smooth muscle membrane depolarization (i.e. a more positive Em) activates 
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VDCC and causes smooth muscle contraction, whereas membrane 
hyperpolarization (i.e. a more negative Em) causes smooth muscle relaxation. 
This phenomenon is termed “electromechanical coupling” (Somlyo and Somlyo, 
1968), and is also an important determinant of vascular tone. 
 
Arterial smooth muscle Em is determined by the distribution of various kinds of 
ions across the membrane, and their respective permeability. The principal ions 
in question are the sodium (Na+), Ca2+, K+, and chloride (Cl–) ions. The 
membrane conductance associated with K+ channel activity accounts for about 
70% of its total conductance (Nelson and Quayle, 1995), and this is about 10 
times that of Cl– and 200 times that of Na+ (Hirst and van Helden, 1982). Thus 
Em is dominated by the distribution of K+ across the plasma membrane in 
smooth muscle, which gives an equilibrium potential (EK) of -84 mV (Hirst and 
Edwards, 1989). This predominance of electric conductance for K+ actually 
makes the plasmalemmal K+ channel the major regulator of arterial smooth 
muscle Em (Nelson and Quayle, 1995). When more K+ channels remain in the 
open state (i.e., hyperactivity), the increased membrane conductance for K+ 
drives Em further toward EK, and the cell membrane is hyperpolarized. 
Conversely, when less K+ channels remain in the open state, Em then 
equilibrates toward the equilibrium potential of Cl– (-31 mV) and the cell 
membrane is depolarized. Through the subsequent electromechanical coupling, 
the arterial smooth muscle K+ channel becomes able to regulate vascular tone. 
Drugs that open the vascular K+ channel indeed cause hypotension, whereas 
drugs that inhibit the channel elevate blood pressure (see below). 
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Several kinds of K+ channel are expressed in the arterial smooth muscle cell 
membrane (for review, see Nelson and Quayle, 1995). These are the voltage-
dependent (KV) channel, the Ca2+-activated (KCa) channel, the inwardly 
rectifying (KIR) channel, the KATP channel, and the two-pore domain (K2P) 
channel (Gurney and Manoury, 2009). The KV channel is activated by 
membrane depolarization, while elevations in [Ca2+]i activate the KCa channel. 
Therefore, these two channels function to prevent excessive depolarization and 
hence limit smooth muscle contraction. The KIR channel contributes importantly 
to the resting K+ conductance, and may be responsible for hyperkalaemia-
induced vasodilatation (Quayle et al., 1997). The K2P channel also contributes 
to background K+ conductance, and may be involved in arachidonic acid- and 
polyunsaturated fatty acid-induced arterial dilatation and hypoxia-induced 
pulmonary vasoconstriction (Gurney and Manoury, 2009). Since many 
members of this channel family are sensitive to hypoxia and changes in pH, 
they may also contribute to the development of septic shock but to what extent 
remains currently unknown. The KATP channel and, to a lesser extent, the large 
conductance KCa (BKCa) channel have been implicated in the vascular changes 
and consequent hypotension seen in sepsis (for reviews, see Landry and 
Oliver, 2001; Buckley et al., 2006), as they can be directly activated by NO, 
prostacyclin, adenosine and CGRP (Murphy and Brayden, 1995; Nelson et al., 
1995; Clapp and Tinker, 1998). 
 
Several studies demonstrated arterial smooth muscle hyperpolarization induced 
by bacterial endotoxin (lipopolysaccharide, LPS). However, the nature of this 
hyperpolarization appears heterogeneous, depending on the vessel studied, the 
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type of septic stimuli, the presence of endothelium in the preparation, and time. 
(Farias et al., 2002) incubated arterial vessels with LPS for 10 min and found 
that KATP channel activity was only involved in hyperpolarization in aortae from 
spontaneously hypertensive rats (SHR), whereas BKCa channel activity was 
involved in mesenteric arterial bed in normotensive rats. NO released from the 
endothelium did not always stimulate BKCa channel activity, but was the major 
mediator of LPS-induced vasorelaxation in SHR. (Chen et al., 2000) found in ex 
vivo aortae from 6h endotoxemic rats that the nitric oxide synthase (NOS; see 
1.3.3) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME), and the downstream 
soluble guanylate cyclase (sGC; see 1.3.3) inhibitor, 1H-[1,2,4]oxadiazolo[4,3-
a]quinoxalin-1-one (ODQ), attenuated LPS-induced hyperpolarization through 
modulating both BKCa and KATP channel activities. (Kuo et al., 2009) found in ex 
vivo aortae from 18h CLP rats that aortic smooth muscle hyperpolarization was 
attenuated by blockers of BKCa, KV and KIR channels, but not every type of KATP 
channel blockers. Methylene blue, but not L-NAME or ODQ, could also 
attenuate the hyperpolarization, These results actually draw more confusion 
rather than consensus as to the role of vascular K+ channel in sepsis-induced 
vascular changes. 
 
1.3.3. Nitric oxide 
Probably the most important vasoactive mediator induced by sepsis is NO. This 
gas has been identified as the endothelium-derived relaxing factor that 
constitutes a crucial endogenous vasodilator mechanism for regulating blood 
pressure and flow (for review, see Moncada et al., 1991). NO exerts its 
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physiological effects principally through activating sGC, which synthesizes 
guanosine 3’,5’-cyclic monophosphate (cGMP) that subsequently activates the 
cGMP-dependent protein kinase (PKG). In vascular smooth muscle, PKG 
lowers [Ca2+]i in many of the same ways as PKA (see 1.3.1). However, it has 
the additional capability of inhibiting IP3-induced Ca2+ release through 
phosphorylating its receptor (Murthy and Zhou, 2003) as well as stimulating 
Ca2+ uptake into the SR by activating the Ca2+/ATPase through phosphorylation 
of phospholamban, although the latter may also be a target for PKA (Cornwell 
et al., 1991). The cGMP/PKG and cAMP/PKA signalling pathways can “cross-
talk” with each other, and thereby induce similar physiological changes (Lincoln 
et al., 1990). The cGMP/PKG pathway also modulates myosin phosphatase 
and PKC activities, and is thereby able to lower Ca2+ sensitivity of the muscle 
(for review, see Carvajal et al., 2000). NO may also react with the superoxide 
anion to generate the potent oxidizing radical, peroxynitrite, that may cause 
direct cytotoxicity to vascular smooth muscle leading to contractile failure, 
cellular energetic failure (Zingarelli et al., 1997) and apoptosis (Li et al., 2004). 
 
NO is synthesized by NOS, of which three isoforms exist. NOS1 (neuronal) and 
NOS3 (endothelial) isoforms are constitutively expressed, and their activity is 
dependent on Ca2+ and calmodulin. This complex, together with cofactors, 
stimulates the enzyme to produce a brief production of NO at physiological 
levels (picomolar to low nanomolar in plasma), where NO functions principally 
as a neurotransmitter or a signalling molecule. In contrast, NOS2 isoform 
(otherwise known as iNOS) is not constitutively expressed in most tissues, but 
is transcriptionally inducible by bacterial endotoxin and certain pro-inflammatory 
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cytokines. Its activity does not depend on Ca2+ (because calmodulin is already 
tightly bound) and, compared to the other NOS isoforms, can produce hundred-
to-thousand-fold higher levels of NO (high nanomolar to low micromolar plasma 
concentrations), and for many hours. High levels of NO have both antimicrobial 
and cytotoxic effects. It may also play an important role in shaping the immune 
response (for reviews, see Fang, 1997; Bogdan, 2001b). However, high levels 
of NO contribute to the vasodilatation and consequent hypotension seen in 
sepsis (for review, see Thiemermann, 1997). 
 
Many believe that induction of NOS2 leading to excessive generation of NO 
represents the primary cause of septic shock. However, in human sepsis, 
induction of NOS2 appears not to be as widespread or as marked as that seen 
in rodent models of endotoxic shock (Vallance and Charles, 1998), even though 
NOS inhibitors are potent pressor agents. In skin/soft tissue biopsies taken from 
patients with necrotising fasciitis NOS2 activity was found to be compart-
mentalized (Annane et al., 2000). In addition, there was a significant inverse 
correlation between plasma levels of nitrate and nitrite (collectively referred to 
as NOx, a surrogate marker of in vivo NO synthesis) and the mean arterial 
pressure (MAP) and systemic vascular resistance. However, a clinical trial of a 
non-specific NOS inhibitor in septic shock patients caused more deaths than 
the control group treated conventionally with catecholamines (Lopez et al., 
2004). In this multi-centre clinical trial, the sepsis-induced vascular changes 
could not be fully reversed in some patients at the highest dose allowable. This 
dose should, in theory, be sufficient to block NOS completely. In an animal 
study using endotoxaemic rats, even when the NOS2 induction was fully 
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suppressed by pre-treatment with dexamethasone and aminoguanidine, plasma 
NOx level did not rise yet their aortae still had higher nitrate and cGMP levels, 
and still showed an attenuated in vitro pressor response to NE (Wu et al., 1998). 
These results could originate from an increase in NOS1 and/or NOS3 activity or 
some other factor induced by sepsis like carbon monoxide that could stimulate 
downstream sGC activity (Wu et al., 1994). Notwithstanding this, the plasma 
NOx level did not appear to reflect these activities.  
 
Considering these results, should more broad-based drugs be used 
therapeutically, e.g. methylene blue (Wu et al., 1998), which will completely 
suppress both NOS and guanylate cyclase activity? Unfortunately, a complete 
wipeout of NO may not be totally beneficial, as NO remains important in 
modulating the immune response. NOS2 gene-knockout (KO) mice can either 
have a better (Hollenberg et al., 2000), similar (Laubach et al., 1995), or worse 
(Cobb et al., 1999) outcome after sepsis. Therefore, the potential benefits and 
risks of modulating NOS and the cGMP/PKG pathway need to be carefully 
evaluated. 
 
1.3.4. Dysfunction in compensatory mechanisms 
As previously described, hypotension may be the result of overproduction of NO 
(and other mediators) overwhelming the compensatory mechanisms in 
maintaining blood pressure. Alternatively, it could also be that sepsis renders 
these mechanisms dysfunctional through affecting the production, receptors or 
downstream pathways of vasoconstricting hormones. Plasma NE, renin (the 
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proteolytic enzyme that generates the precursor of angiotensin II) and 
vasopressin levels were markedly elevated in conscious endotoxaemic rats 
(Schaller et al., 1985). Receptors for each of these vasoconstrictors are down-
regulated during sepsis (Bucher et al., 2001; Bucher et al., 2002; Bucher et al., 
2003). Moreover, the activity of the angiotensin converting enzyme (ACE), 
which catalyses the generation of angiotensin II, was also found to be reduced 
during experimental and human sepsis (Deitz et al., 1987; Dunn and Horton, 
1993). Similarly, plasma vasopressin levels tend to fall back toward baseline 
after prolonged (≥24h) septic shock in humans (Landry et al., 1997). Thus it 
may not be surprising that intravenous infusion of angiotensin II (Wan et al., 
2009) or vasopressin (Landry et al., 1997) helped to reverse sepsis-induced 
hypotension. Despite this, a large clinical trial of vasopressin failed to 
demonstrate an overall survival benefit in septic shock patients compared to NE 
alone (Russell et al., 2008). However, vasopressin doses used were low and an 
a priori defined subset of patients with lower pressor requirements did show 
statistically significant survival benefit with vasopressin. Angiotensin II infusion 
was also shown to beneficially increase urine output and creatinine clearance in 
experimental hyperdynamic sepsis (Wan et al., 2009). However, one recent 
animal study showed that administration of ACE inhibitors actually decreased 
the mortality from multi-organ dysfunction (Schmidt et al., 2010). In summary, 
derangement of compensatory mechanisms during sepsis may also contribute 
to arterial vasodilatation, but whether this derangement is primarily induced by 
sepsis or a secondary change following other insults remains to be clarified. 
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Experiments performed by Banet and Guyton (1971) elegantly demonstrated 
the relationships between sympathetic stimulation, cardiac output and arterial 
blood pressure. Dogs were continuously infused with 2,4-dinitrophenol, a proton 
ionophore that dissipates the mitochondrial proton motive force and reduces 
ATP production, thus increasing body oxygen consumption about fourfold. This 
resulted in diffuse arteriolar dilatation and reflex sympathetic stimulation, a 
scenario similar to that happens in sepsis. With an intact central nervous 
system, the dog could increase its cardiac output threefold, and the arterial 
pressure could be maintained. However, in dogs that had been decapitated and 
their spinal cords destroyed, the arterial pressure could not be maintained and 
there was an increase in cardiac output of only 50%. Interestingly, if the 
decapitated dogs were transfused intra-arterially with blood or blood mixed with 
dextran solution to maintain their arterial pressure, their cardiac output could 
also be increased to the same as intact animals. These results suggest that the 
heart has a functional reserve that can tremendously increase cardiac output to 
maintain arterial pressure, provided the sympathetic reflex or the intra-arterial 
blood volume (or the pressure generated from filling the vessels) remains 
adequate. During septic shock, cardiac output is, in general, not increased as 
much, so this may also contribute to the development of hypotension. Problems 
may arise from myocardial depression, suboptimal cardiac preload, derange-
ment of sympathetic reflexes, or/and an increase in arterial compliance. 
Endotoxin could blunt the muscle sympathetic nerve activity in response to the 
baroreceptor reflex, and uncouple heart rate modulation with that for blood 
pressure (Sayk et al., 2008). The baroreceptor reflex may also be affected by 
angiotensin II (Polson et al., 2007) and vasopressin (Koshimizu et al., 2006). 
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Therefore, sepsis may render the sympathetic nervous system dysfunctional, 
and this may also contribute to the development of arterial dilatation and the 
consequent hypotension. 
 
1.4. Vascular KATP channels 
KATP channels are so called because they respond to fluctuations in intracellular 
ATP concentrations ([ATP]i) and open and close in response to metabolic 
demand (Noma, 1983). Under physiological concentrations (millimolar) of 
intracellular ATP, channel opening is rare (Quayle et al., 1994). In contrast, 
nucleoside diphosphates (NDP) are able to activate the channel, even in the 
presence of normal [ATP]i (Beech et al., 1993). Thus, the ratio of ATP to NDP 
within the cell becomes a key determinant of basal activity of the channel in 
many tissues (Seino and Miki, 2003). 
 
KATP channels are inhibited by sulphonylurea agents such as glibenclamide, 
glipizide and tolbutamide which bind to the sulphonylurea receptor (SUR) 
subunit of the channel (see 1.4.1). A chemically diverse group of KATP channel 
openers (KCOs) that include agents such as levcromakalim, pinacidil, 
diazoxide, minoxidil and nicorandil also interact with the SUR but in contrast 
activate the channel and cause substantial hypotension in vivo (Mannhold, 
2004). 
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1.4.1. An hetero-octomer of two subunits in a 1:1 stoichiometry 
The structure of KATP channels consists of a hetero-octomer of two subunits in a 
1:1 stoichiometry (Figure 1.2). Four subunits belonging to the inwardly rectifying 
KIR6.x channel protein family form the pore (Inagaki et al., 1995), while 4 SUR 
regulatory subunits belonging to the ATP-binding cassette family of proteins 
(Aguilar-Bryan et al., 1995) surround them; both are required to form a fully 
functional channel (see below). Glibenclamide and KCOs exert their effect 
through binding to the SUR subunit, as do NDP, whereas ATP binds to the 
pore-forming subunit to inhibit the channel (Figure 1.2). However, high doses of 
glibenclamide may also inhibit the pore (Bryan and Aguilar-Bryan, 1999). 
Isoforms of each of the subunits have been identified: KIR6.1 (encoded by the 
gene KCNJ8 in human) and KIR6.2 (KCNJ11) for the pore-forming subunit; 
SUR1 (ABCC8) and SUR2 (ABCC9) for the regulatory subunit. Two major 
splice variants exist for the SUR2 gene, giving rise to either SUR2A or SUR2B 
protein. In different tissues, different compositions of KIR6.x/SUR are 
represented: KIR6.2/SUR1 channels in pancreatic β-cells and neurons, 
KIR6.2/SUR2A in cardiac and skeletal muscles and KIR6.1/SUR2B in vascular 
smooth muscle (for reviews, see Seino and Miki, 2003; Buckley et al., 2006). 
Another KATP channel inhibitor particularly important in the current study is PNU-
37883A (Humphrey, 1999), which binds specifically to the vascular isoform of 
the pore-forming subunit (Cui et al., 2003; Teramoto, 2006). Thus it is not 
surprising that PNU-37883A had little effect on cardiac or β-pancreatic cloned 
KATP channels (Cui et al., 2003). 
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Figure 1.2. Structure of the KATP channel. a) KATP channels are composed of two 
subunits. The pore-forming subunit consists of KIR6.x, which belongs to the inwardly 
rectifying K+channel protein family. The regulatory subunit, termed the sulphonylurea 
receptor (SUR), belongs to the ATP-binding cassette protein family. TMD = trans-
membrane domain; NBF = nucleotide binding fold. b) Functional channels are hetero-
octomers, which consist of 4 KIR6.x and 4 SUR subunits in a 1:1 stoichiometry. c) 
Images at 18Å resolution of the KATP channel complex in the plane of the membrane 
(left) and from above the membrane (right). Domains in the 3-dimentional model are 
represented in the same colour as that for their respective domains in (a). Figure 
reproduced from Nichols (2006) by permission from Macmillan Publishers Ltd. 
KIR6.x SUR 
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Pancreatic KATP channels dominate the resting K+ permeability of the β-cell in 
the absence of glucose (Ashcroft and Rorsman, 1989). Hyperglycaemia leads 
to an increase in [ATP]i, which inhibits the KATP channel and thereby depolarize 
the cell. The resultant activation of the VDCC and increase in [Ca2+]i stimulate 
the release of insulin from β-cells (Petit and Loubatières-Mariani, 1992). 
Myocardial KATP channels, activated by the raised [ADP]i resulting from 
ischaemia, exert protective effects on cardiac muscle through shortening the 
action potential duration and decreasing Ca2+ loading (Nichols and Lederer, 
1991). However, certain myocardial KCOs protect ischaemic/reperfused 
myocardium that appears independent of these two effects, suggesting the 
existence of other protective mechanisms or sites of action of these agents 
(Grover and Garlid, 2000). Amongst is the mitochondrial KATP (mitoKATP) 
channel located in the inner membrane of mitochondria, which can be activated 
by the KCO, diazoxide, at thousand-fold lower concentrations compared to 
sarcolemmal KATP channels (Garlid et al., 1996). At this mitoKATP-selective level, 
diazoxide exerts protective effects on myocardium during ischaemia, which can 
be abolished by the inhibitor of the mitoKATP channel, 5-hydroxydecanoic acid 
(Garlid et al., 1997). Thus the KATP channels in different tissues can exert a 
variety of effects important to normal physiology. 
 
1.4.2. Channel subunit gene expression 
According to the AceView annotations of the National Center for Biotechnology 
Information rat genome database (http://www.ncbi.nih.gov/IEB/Research 
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/Acembly/ ; Thierry-Mieg and Thierry-Mieg, 2006), the Kcnj8 gene is expressed 
at low level, whereas the Abcc9 is moderately expressed.  
 
Several transcription factors are implicated in regulating KATP subunit gene 
expression, for example, the Forkhead (Foxs) (Philip-Couderc et al., 2008); the 
nuclear factor (NF)-κB (Shi et al., 2010), Sp1 (Ashfield and Ashcroft, 1998; 
Hernández-Sánchez et al., 1999), E-box and activating protein (AP)-2 (Ashfield 
and Ashcroft, 1998), Isl-1 (Hashimoto et al., 2005), and hypoxia-inducible factor 
1α (Raeis et al., 2010). NF-κB and Foxs are particularly relevant to sepsis, as 
they can be induced by bacterial endotoxin (Cohen, 2002) or/and the 
inflammatory mediator, tumour necrosis factor (TNF)-α (Isidoro Tavares et al., 
2009). Other factors that have been shown to affect gene expression of these 
two subunits include hypoxia (Crawford et al., 2003), dexamethasone 
(Hernández-Sánchez et al., 1999; d'Emmanuele di Villa Bianca et al., 2003), 
growth hormone (Tivesten et al., 2004), 17β-estradiol (Ranki et al., 2002), high 
glucose concentrations and diabetes (Moritz et al., 2001; Ren et al., 2003) as 
well as hypercholesterolaemia (Ren et al., 2001). Importantly, dexamethasone 
significantly reduced KCO-induced hypotension in endotoxaemic rats in a time-
dependent manner, suggesting the presence of de novo synthesis of vascular 
KATP channels (d'Emmanuele di Villa Bianca et al., 2003). 
 
Importantly, the synthesis of the pore-forming subunit does not necessarily lead 
to the constitution of more functioning channels. As the KIR6.2 subunit rapidly 
degraded if not binding to SUR1 (Crane and Aguilar-Bryan, 2004), it is likely 
that the number of the existing SUR molecules actually determines how many 
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functioning channels can eventually be formed. Indeed, (van Bever et al., 2004) 
overexpressed KIR6.2 subunit by 7-fold, resulting in only a 58% increase in 
cultured ventricular myocyte KATP current density. Their result also indicates the 
presence of a reserve of SUR1 in the myocyte that can accommodate 
additional KIR6.2. Jin et al. (2004) saw a 22-fold increase in KIR6.1 expression in 
colonic smooth muscle cells induced by chronic inflammation, concomitant with 
an increase in KATP current density by only 2.5-fold. Taken together, the 
increase in KIR6.1 transcriptional expression during sepsis may not correlate 
well with the concurrent change in KATP channel activity. 
 
1.4.3. Surface expression and turnover 
After gene translation, the subunit proteins are assembled into functional units 
of (KIR6.x/SUR)4 and trafficked to the plasma membrane to exert their function. 
KIR6.x and SUR1 subunits both possess an endoplasmic reticulum retention 
signal that is an arginine-lysine-arginine motif. This is hidden during their correct 
incorporation into a functional channel, thus granting access to the plasma 
membrane (Zerangue et al., 1999). For KIR6.2/SUR1 KATP channels, (Crane and 
Aguilar-Bryan, 2004) showed that after 60 min of labeling with [35S] methionine/ 
cysteine, the newly synthesized KIR6.2 and SUR1 rapidly associated with each 
other, and their complexes became detectable in 10 min. Then these 
KIR6.2/SUR1 complexes assembled themselves into tetramers, which were then 
transitted to the Golgi apparatus wherein the SUR was glycosylated. The 
labeled mature channels appeared within 2h, and reached the maximum 
 41 
number at about 10h. The estimated half-life for the complete, fully glycosylated 
channel is about 7.3h. 
 
1.4.4. Physiological roles of vascular KATP channels 
As mentioned previously, KATP channels are inhibited by intracellular ATP and 
sulphonylurea agents, and opened by NDP and KCOs. However, KATP channels 
do not simply respond to cell metabolism, since other factors including kinases 
(Standen and Quayle, 1998; Thorneloe et al., 2002; Lin et al., 2004), 
phosphatases (Wilson et al., 2000), G-proteins (Terzic et al., 1994), and 
phospholipids (Baukrowitz and Fakler, 2000) also regulate channel activity and 
contribute to physiological regulation (Figure 1.3). Likewise, during conditions of 
metabolic stress such as ischaemia or hypoxia, where [ATP]i falls and [NDP]i 
rises, channel opening becomes substantial (Rodrigo and Standen, 2005). This 
serves to match blood flow to metabolic demand.  
 
In arterial smooth muscle, KATP channels contribute to the maintenance of 
resting Em and local blood flow. This is based upon observing significant effects 
of glibenclamide on Em, vascular resistance, and blood vessel diameter (Bonev 
and Nelson, 1993a; Jackson, 1993; Duncker et al., 2001). KATP channels can be 
activated by vasodilator hormones elevating cAMP (e.g., CGRP, adenosine, 
and prostacyclin) or cGMP (e.g., atrial natriuretic peptide and NO) (Kleppisch 
and Nelson, 1995; Quayle et al., 1997). By contrast, vasoconstrictor agents 
activating PKC (e.g. endothelin, angiotensin II, vasopressin) close these 
channels (Nelson and Quayle, 1995) (Figure 1.3). Thus, the KATP channel not 
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only regulates Em in normal physiology, but also serves as a target for various 
circulatory stimuli and pharmacological tools. 
 
The physiological role of vascular KATP channels has been further elucidated 
using a gene-knockout approach. Both KIR6.1 and SUR2 KO mice were prone 
to sudden death, and this was attributed to coronary vasospasm owing to the 
disruption of the channel (Chutkow et al., 2002; Miki et al., 2002). The coronary 
vasospastic episodes were reduced by nifedipine, a L-type VDCC blocker, 
confirming the link between VDCC and KATP channel activity. SUR2 KO and 
KIR6.1 KO mice also developed hypertension (Chutkow et al., 2002; Kane et al., 
2006). In addition, enhanced expression of KIR6.1 and SUR2B subunits induced 
by growth hormone significantly correlated with a reduction in blood pressure 
(Tivesten et al., 2004). Thus, vascular KATP channels seem to play an active 
role in modulating blood pressure in normal physiology. 
 
Of note, the activity of vascular KATP channels can be inhibited by an elevated 
[Ca2+]i. The host lab previously found that the KATP current of RASMC was 
almost completely inhibited by a raised [Ca2+]i (IC50 = 100 nM). This inhibition 
appears to relate to the Ca2+-dependent protein phosphatase-2B, calcineurin, 
as cyclosporin A, FK-506 or calcineurin autoinhibitory peptide that inhibits 
calcineurin could increase KATP channel activity (Wilson et al., 2000). Therefore, 
vasoconstricting stimuli can inhibit the channel not only through increasing PKC 
activity but also through increasing [Ca2+]i. 
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Figure 1.3. Modulating pathways of KATP channels in arterial smooth muscle. 
Vasoconstrictors, through phospholipase C-β (PLCβ), activate protein kinase C (PKC), 
which phosphorylates the KATP channel, closing it and thereby causing depolarization 
and the opening of the voltage-dependent Ca2+ channel (VDCC). Vasodilatory 
receptors activate the KATP channel through adenosine 3’,5’-cyclic monophosphate 
(cAMP)-dependent protein kinase (PKA)-dependent phosphorylation. Nitric oxide (NO), 
peroxynitrite (ONOO-), reactive oxygen species (ROS) and guanosine 3’,5’-cyclic 
monophosphate (cGMP) combine to activate the KATP channel in sepsis. (Adapted from 
Buckley et al., 2006, by permission of the European Society of Cardiology). 
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1.5. Vascular KATP channel hyperactivity during septic shock 
Increasing evidence suggests that abnormal activation of KATP channels 
contributes to sepsis-induced cardiovascular collapse (for review, see Buckley 
et al., 2006). Sepsis induces release of many mediators known to activate KATP 
channels (e.g., CGRP, adenosine), whereas other factors, such as acidosis, 
hyperlactataemia, changes in intracellular adenosine nucleotide composition, 
and excessive NO generation may provoke further KATP channel hyperactivity. 
 
However, this notion is not without challenge. Many, but not all, in vivo animal 
models of LPS-induced shock have shown that hypotension could be restored 
by administration of the KATP channel inhibitor, glibenclamide, at dosages of 10-
40 mg·kg-1 i.v. (Landry and Oliver, 1992; Gardiner et al., 1999; Sorrentino et al., 
1999) Glibenclamide also increased pressor responses to α1-adrenoreceptor 
agonists (Landry and Oliver, 1992; Sorrentino et al., 1999). This is in direct 
contrast to all in vitro and ex vivo tissue models to date, where glibenclamide 
failed to reverse vascular hyporeactivity (e.g., Taguchi et al., 1996; Sorrentino 
et al., 1999). Similarly, it does not show any pressor effect in patients with septic 
shock (Warrillow et al., 2006; Morelli et al., 2007; Singer et al., 2005), although 
it markedly reversed vascular hyporeactivity and reduced catecholamine 
requirements in hypo-tensive patients with excessive pharmacologic K+ channel 
activation (Singer et al., 2005). To address this discrepancy, the host lab used 
an in vitro organ culture model of rat mesentery artery and found that channel 
inhibitors acting on the pore-forming subunits (namely, PNU-37883A and the 
barium ion) could fully reverse LPS-induced vascular hyporeactivity at 6h, and 
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remained able to partially reverse hyporeactivity at 20h (O'Brien et al., 2005). 
Similar findings were observed in rat thoracic aortae (Wilson and Clapp, 2002), 
where only KATP channel antagonists acting on the pore could reverse the 
NOS2-mediated relaxation. In the latter study, the ability of glibenclamide to 
reverse KCO relaxation was greatly diminished in the presence of LPS whereas 
the pore blockers remained relatively effective. Moreover, mice lacking the 
KIR6.1 gene did not become hypotensive following endotoxin administration 
((Kane et al., 2006). These results not only suggest the involvement of the KATP 
channel in the pathogenesis of sepsis-induced vascular hyporeactivity, but also 
indicate that KATP hyperactivity might originate from either a defect in the 
regulatory function of the SUR subunit, a defect in the communication between 
the pore and the regulatory subunits, and/or mechanisms that involve the pore-
forming subunit only. 
 
The host lab continued to investigate the in vivo pressor effect of PNU-37883A 
and high-dose glibenclamide in a rat model of endotoxic shock (O'Brien et al., 
2009). Rats were anaesthetized with isoflurane and fluid resuscitated after i.v. 
infusion of Klebsiella pneumoniae endotoxin. Drugs were infused two hours 
later. While PNU-37883A and high-dose glibenclamide were capable of 
increasing arterial pressure, a more profound pressor effect was observed in 
sham-operated rats. This goes against the hypothesis that sepsis can induce 
vascular KATP channel hyperactivity, in which case an accentuated pressor 
response should be present in endotoxic rats. Aside from the theoretical 
plausibility that the vascular KATP channel can be activated by sepsis and cause 
vascular changes pathognomonic to septic shock, it seems never known 
 46 
whether channel hyperactivity is actually present and to which extent does this 
contribute to the vascular changes during sepsis. 
 
One concern has been the anesthetics used in this study, isoflurane, which is a 
KATP channel activator (Iida et al., 1998) and may thus potentiate the sham rat’s 
pressor response to KATP channel inhibition. Except for two studies (Gardiner et 
al., 1999; Lange et al., 2006), all studies showing an enhanced pressor effect of 
glibenclamide in septic animals were performed in anaesthetized animals. 
Importantly, most if not all anaesthetic agents appear capable of modulating 
vascular KATP channel activity (Kato et al., 2000; Kawano et al., 2004, 2005; 
Nakamura et al., 2007). Anaesthesia may also affect the reflex control of blood 
pressure, posing additional confounding effects on the experimental results 
(Matsukawa and Ninomiya, 1989). 
 
Supposing KATP channel hyperactivity is induced during sepsis, what might be 
its origin? Upregulation of channel function may relate to increased channel 
opening and/or channel number. Enhanced KCO relaxation, vascular 
hyporeactivity and the pressor effect of glibenclamide at 24h after LPS could be 
prevented by pre-treatment with dexamethasone (d'Emmanuele di Villa Bianca 
et al., 2003), suggesting de novo synthesis of channel subunits during sepsis. 
Indeed, messenger RNA (mRNA) levels for KIR6.1 increased in the diaphragm 
of LPS-treated rats at 24h (Czaika et al., 2000), in mice with experimental colitis 
(Jin et al., 2004), and following ischaemia/reperfusion in rat heart (Akao et al., 
1997). Therefore, one possible cause of KATP channel hyperactivity during 
sepsis might be an enhanced transcriptional expression of KATP subunit genes. 
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Shi et al. (2010) showed that murine aortae exposed in vitro to LPS (1 µg·ml-1) 
for 20 h had a one- to twofold increase in KIR6.1 gene expression, and a 50% 
increase in SUR2B expression. This channel induction was through NF-κB 
activity, and was accompanied by a 50% increase in basal KATP current density. 
I sought to confirm the presence of a similar channel subunit gene induction in 
vivo. 
 
1.6. Summary and aims 
Septic shock is characterized by systemic vasodilatation, which may originate 
from the excessive production of NO, derangement of compensatory 
mechanisms, and activation of the vascular KATP channel. Current data remain 
controversial as to the extent to which KATP channel hyperactivity contributes to 
the development of hypotension, and the feasibility of inhibiting the channel to 
restore blood pressure and the pressor response to catecholamine. In vitro 
experiments demonstrated the presence of vascular KATP channel hyperactivity 
induced by LPS that is related to an enhanced channel subunit gene 
expression. Does the same phenomenon occur in septic patients or animals in 
vivo? 
 
The aims of this thesis are to investigate whether sepsis increases vascular 
KATP channel number through inducing channel gene expression, and the 
feasibility of inhibiting the channel to reverse the sepsis-induced vascular 
changes. The first aim was to demonstrate the presence of vascular KATP 
channel hyperactivity and a corresponding increase in gene expression, using 
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an in vitro primary cell culture model and an ex vivo model of arteries taken 
from septic rats. The second aim of this project was to explore the feasibility of 
in vivo vascular KATP channel inhibition as a treatment modality to septic shock, 
especially through using PNU-37883A to block the pore. I observed the 
respective effect of PNU-37883A and other study drugs on arterial blood 
pressure and the pressor response to catecholamines in a fluid-resuscitated rat 
model of peritonitis. In light of the potential confounding effects from the 
anaesthetic agents used in previous studies, I chose to observe these events in 
conscious rats. 
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Chapter Two Methods and Experimental Protocol 
Chapter 2. Methods and Experimental Protocol 
 
I initially used a primary cell culture model of rat aortic smooth muscle cells 
(RASMC) to observe the effect of inflammatory stimuli on vascular KATP channel 
expression and functional activity. After finding increased channel gene 
expression using reverse transcription polymerase chain reaction (RT-PCR) 
and a corresponding increase in channel activity, I subsequently observed the 
level of channel gene expression and activity in arterial smooth muscle taken 
from septic animals. For this purpose I set up an animal model that mimics 
clinical sepsis as the source of ex vivo arterial tissues. Finally, I sought to 
establish the therapeutic efficacy of the KATP channel pore blocker, PNU-
37883A, in reversing sepsis-induced hypotension and vascular hyporeactivity in 
this in vivo model. 
 
Figure 2.1 schematically shows the protocol I used in the in vivo study that 
utilized a 24h conscious rat model of faecal peritonitis. I observed the ability of 
NOS inhibition or vascular KATP channel blockade to reverse the sepsis-induced 
vascular changes, namely vasodilatation and consequent hypotension, and the 
attenuated pressor response (i.e. vascular hyporeactivity) to catecholamines. I 
then sacrificed the animals and collected their thoracic aortae and mesenteric 
arteries to measure levels of vascular KATP channel gene expression and 
functional activity. For this latter study, no previous drug treatment was given to 
the animals prior to tissue collection. 
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Figure 2.1. Schematic of the protocol used for in vivo experiments. ip = 
intraperitoneal; iv = intravenous; BP = blood pressure; qRT-PCR = quantitative reverse 
transcription polymerase chain reaction; 86Rb+ = 86rubidium. 
 
 
2.1. Primary culture of rat aortic smooth muscle cells 
2.1.1. Cell harvest and characterization 
RASMC were isolated using a method devised by (Clapp and Gurney, 1991). 
Briefly, male Wistar rats (Charles River, Margate, Kent) of 200-250g body 
weight were killed by cervical dislocation after stunning. The aorta was excised 
and kept in ice-cold normal Ca2+ solution (in mM: NaCl 112, KCl 5, CaCl2 1.8, 
MgCl2 1, NaHCO3 15, NaH2PO4 0.5, KH2PO4 0.5, glucose 11, 4-(2-hydroxy-
ethyl)-1-piperazineethane-sulphonic acid [HEPES] 5, phenol red 0.04; pH 7.3). 
After dissecting off the surrounding tissue, the aorta was opened longitudinally, 
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and the endothelium removed by rubbing with a cotton swab. The media layer 
was carefully stripped off the adventitial layer and separated into ~3 × 3-5 mm 
pieces. These were washed twice in the dissociation medium (in mM: NaCl 110, 
KCl 5, CaCl2 0.16, MgCl2 2, NaHCO3 10, NaH2PO4 0.5, KH2PO4 0.5, glucose 
10, HEPES 10, ethylenediaminetetraacetic acid [EDTA] 0.49, taurine 10, phenol 
red 0.04; pH 7.0 after CO2 bubbling for 30 min just before use) and then 
incubated overnight (for about 17h) at 4ºC in 5 ml of fresh dissociation medium 
containing 0.4 mg⋅ml-1 papain (derived from Carica papaya, activity 11.5 U⋅mg-1; 
Fluka, Gillingham, Dorset) and 0.02% bovine serum albumin (BSA; essentially 
fatty acid free). The next morning, 0.1 mM dithiothreitol (DTT) was added to the 
dissociation medium, and the muscle pieces incubated at 37ºC in a shaking 
water bath at 40-50 oscillations per min for 15 min. After incubation the muscle 
pieces were transferred to fresh dissociation medium and gently triturated with a 
wide-bore (2-3 mm) Pasteur pipette. Relaxed single cells were thus isolated and 
then plated in a T25 flask in the dissociation medium. After cells had been 
allowed to settle, the medium was changed to Smooth Muscle Basal Medium 
(Lonza, Slough, Berks) supplemented with Smooth Muscle Growth Medium-2 
SingleQuots (Lonza) that contains human epidermal growth factor, insulin, 
human fibroblast growth factor-basic, fetal bovine serum (FBS) and gentamicin/ 
amphotericin-B. Three days later, the medium was switched to Dulbecco’s 
modified Eagle’s medium (DMEM)/Ham’s F-12 (PAA Laboratories, Yeovil, 
Somerset) supplemented with 10% FBS (Gibco, Paisley, Renfrew), 50 units⋅ml-1 
penicillin, and 50 µg⋅ml-1 streptomycin (Gibco). Ninety seven percent of cells 
were characterized as smooth muscle cells by morphology and immunostaining 
with antibodies (Sigma-Aldrich, Gillingham, Dorset) to smooth muscle α-actin. 
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2.1.2. Cell culture 
RASMC were plated out on Day 0 and were grown in DMEM/Ham’s F-12 
supplemented with 10% FBS (PAA Labs), 50 units⋅ml-1 penicillin, and 50 µg⋅ml-1 
streptomycin. Culture medium was changed on Days 3 and 5, and the cells 
were then subcultured on Day 7. Cells were washed twice with pre-warmed 
phosphate buffered saline (PBS; Gibco), and were then trypsinized with 0.05% 
trypsin/0.53 mM EDTA (Gibco) (2 ml per T-75 flasks) for less than 5 min. Five 
volumes of DMEM/Ham’s F-12 containing 10% FBS was then added to 
neutralize the activity of trypsin, and the cells were then pelleted by 
centrifugation at 200g for 3 min. The cells were then resuspended in 
DMEM/Ham’s F-12 containing 10% FBS, 50 units⋅ml-1 penicillin and 50 µg⋅ml-1 
streptomycin and subcultured at a split ratio of 1:5. For cells subject to 
experiments, low-endotoxin FBS (PAA labs) was used for subculture. 
 
RASMC between passages 5 and 12 (inclusive) were used for all experiments. 
When reaching ~80% confluence (on Days 7–8), cells were serum-starved by 
growing in DMEM/Ham’s F-12 containing 0.4% low endotoxin FBS, 50 units⋅ml-1 
penicillin and 50 µg⋅ml-1 streptomycin for 48h before giving the septic stimulus 
(see below). The purpose of serum starvation was to render RASMC quiescent 
and to synchronize the growth status among cells to the G0 phase. I wished to 
exclude the possible effects of growth on KATP subunit gene expression as the 
host lab had previously reported that this down-regulated KATP channel activity 
(Cui et al., 2002). Indeed, I observed the current set of experiments that 
growing cells contained only a weak message for KIR6.1 (data not shown). 
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2.1.3. Cell preparation for experiments 
For each sample in each condition, a T-75 flask of RASMC grown to 70-80% 
confluence was used. Quiescent RASMC were treated with a combination of 
Salmonella typhosa LPS (1 µg⋅ml-1; Sigma-Aldrich) and interleukin (IL)-1β (10 
ng⋅ml-1 ; R&D Systems, Abingdon, Oxon) in DMEM/Ham’s F-12 containing 0.4% 
low-endotoxin FBS for 48h. A batch of RASMC was pre-treated with the 
selective NOS2 inhibitor N-(3(aminomethyl)benzyl)acetamidine (1400W, 10 µM; 
Sigma-Aldrich) for 1h before and during the entire period of LPS and IL-1β 
treatment. 
 
The effect of the septic stimulus on cell viability was assessed with the trypan 
blue dye-exclusion method (Freshney, 2005). Briefly, RASMC were washed 
with PBS, trypsinized, and then resuspended in serum-containing culture 
medium as above. Pelleted cells were resuspended by mixing an equal volume 
of cell culture medium and 0.5% trypan blue dye to constitute a cell suspension 
at a density of 5 × 105 cells⋅ml-1. Cells were incubated for 2 min at room 
temperature, and then 10 µl of the cell suspension transferred to the 
haemocytometer (Improved Neubauer). Viable cells are impermeable to trypan 
blue, whereas damaged cells become stained as they take up the dye due to a 
breakdown in membrane integrity. The total number of cells and the number of 
stained cells were counted and the mean value of 4-8 counts taken. 
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2.2. In vivo rat model of faecal peritonitis 
2.2.1. Animal preparation 
Experiments were performed with Home Office (United Kingdom) approval 
(Licence Number: PPL 70/6143; Principal Licence Holder: M Singer) in 
accordance with the Animal (Scientific Procedures) Act 1986. Male Wistar rats 
(Charles River) of ~300g body weight were used throughout. Before 
instrumentation, animals were housed in the local animal unit for five days’ 
prior, where they kept on a 12:12-h light-dark cycle with free access to food and 
water. 
 
Under 2% isoflurane (Abbott Laboratories, Queensborough, Kent) anaesthesia 
maintained via a face mask, the rats were instrumented as follows: the internal 
jugular vein was cannulated for fluid and drug administration, and the carotid 
artery cannulated for blood pressure measurement and blood sampling. The 
catheters (internal diameter, 0.58 mm, external diameter, 0.96 mm) were 
tunneled subcutaneously to emerge at the nape of the neck where they were 
mounted onto a swivel/tether system that enabled the rat, on recovery from 
anaesthesia, to have unimpeded movement around the cage and free access to 
food and water. Both catheters were flushed continuously with 0.15 ml⋅h-1 
heparinized saline (1:1,000). Mean arterial pressure (MAP) was measured 
(P23XL transducers, Viggo-Spectramed, Oxnard, CA, USA) and recorded onto 
a pre-calibrated PowerLab system (ADInstruments, Sydney, Australia). Heart 
rates were derived from the pressure trace records in some of the animals. 
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After instrumentation the rats were allowed to wake from anaesthesia and 
stabilize for 24h, then peritonitis was induced by intraperitoneal injection of 
faecal slurry (4g per kg body weight) prepared from the bowel contents of a rat 
from the same batch. The faecal material was suspended in 0.9% saline to 
constitute 66.7% (w/v) slurry, and then filtered to remove fibrous material. 
Sham-operated control animals received no intraperitoneal injection to avoid 
accidental bowel perforation, but were otherwise treated identically. Fluid 
resuscitation (1:1 solution of 6% hydroxyethyl starch [Voluven, Fresenius Kabi, 
Warrington, Cheshire] and 5% glucose) was given 2h later at 10 ml⋅kg-1⋅h-1 via 
the internal jugular venous catheter. 
 
2.2.2. In vivo drug administration 
The baseline MAP and the changes in MAP induced by various drugs 
administered intravenously were assessed at either 6 or 24h after faecal slurry 
injection. This was performed after arterial and venous catheter patency was 
confirmed and a stable baseline MAP recorded. Drugs for in vivo use were 
diluted in 0.9% saline unless otherwise specified, and were administered 
through a 5-min intravenous (i.v.) infusion with the regular infusion rate of 10 
ml⋅kg-1⋅h-1 was maintained, i.e. no additional volume was administered. Each 
drug infusion was followed by continuous fluid administration to ensure all 
active compound had travelled through the catheter system. The plateau of the 
resultant blood pressure response was recorded. 
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The following drugs were administered, and their effects on baseline MAP and 
vascular reactivity to vasoconstrictors assessed: 
 
(1) Norepinephrine (NE; 0.5 µg⋅kg-1⋅min-1 i.v.): diluted in 5% glucose. 
(2) S-ethylisothiourea (SEITU; 0.1 mg⋅kg-1⋅min-1 i.v.): a potent, non-selective 
NOS inhibitor (Boer et al., 2000). 
(3) PNU-37883A (1.5 mg⋅kg-1 and 1.0 mg⋅kg-1⋅h-1 i.v.; O'Brien et al., 2009): the 
vascular selective KATP channel inhibitor that acts on the pore-forming 
KIR6.1 subunit (Humphrey, 1999; Wellman et al., 1999; Cui et al., 2003). 
(4) Levcromakalim (Lev; 150 µg⋅kg-1 i.v.): a specific KATP channel opener 
(Hamilton et al., 1993). Dissolved in 50% (v/v) polyethylene glycol 200/ 
0.9% saline as 3 mg⋅ml-1 stock solution, which was further diluted with 
0.9% saline to constitute the working solution. 
(5) Midazolam (0.2 mg⋅kg-1 and 0.2 mg⋅kg-1⋅h-1 i.v.): a benzodiazepine that 
exerts a sedative but no analgesic effect. Midazolam has been shown to 
not alter vascular KATP channel activity in vitro (Nakamura et al., 2007). 
(6) Pentolinium (2 mg⋅kg-1 and 2 mg⋅kg-1⋅h-1 i.v.): an autonomic ganglionic 
blocking agent that binds to the nicotinic acetylcholine receptor, thereby 
inhibiting the release of epinephrine and NE from adrenergic nerves. 
Although pentolinium also blocks parasympathetic tone, this effect is often 
far overshadowed by its effect of sympathetic blockade (Waldman and 
Pelner, 1956; Guyton and Hall, 2006); 
(7) Sodium nitroprusside (SNP; 50 µg⋅kg-1⋅min-1 i.v.): a nitrovasodilator; 
(8) Hydralazine (300 µg⋅kg-1⋅min-1 i.v.): a vasodilator that directly relaxes 
arterial smooth muscle. 
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Dose-response curves were created for PNU-37883A (0.001-10 mg⋅kg-1 i.v.) in 
sham and septic rats at 6h (n = 4), and Lev (0.01-300 µg⋅kg-1 i.v.) in sham and 
septic rats at 6 and 24h (n = 3). The dose of PNU-37883A and Lev that 
provoked a change in MAP halfway between baseline and maximum changes 
(EC50) were calculated using the five-parameter logistic equation (Equation 2.1; 
Giraldo et al., 2002;  Prism, GraphPad Software, La Jolla, CA, USA). 
 
A separate batch of rats was pre-treated with reserpine, 4.5 mg⋅kg-1 
subcutaneously 48h & 24h prior to and during instrumentation (Martínez-
Olivares et al., 2006) to deplete their NE reserves from the sympathetic nerves. 
Their responses to PNU-37883A and SEITU at 6h after peritonitis were 
observed. 
 
 
  
! 
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MAPMax –  MAPBaseline
1+10(log Xb "x )  #  Hill slope[ ] S
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log Xb =  logEC50 +
log(2
1
S "1)
Hill slope
 
 
Equation 2.1. Five-parameter logistic equation. Xb indicates the inflection point of 
the curve; S is the unitless symmetric parameter, with a value of 1 indicating a 
symmetric curve (Giraldo et al., 2002). 
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2.2.3. Blood and tissue sampling 
In vivo arterial blood sampling was performed at predetermined time points 
when line patency allowed. Small volumes (~0.2 ml) were collected in 
heparinized capillary tubes for arterial blood gas analysis (ABL-70 analyzer, 
Radiometer, Copenhagen, Denmark), which included measurement of arterial 
base excess, lactate, and PO2. For plasma NOx measurement, blood was 
obtained by cardiac puncture under anaesthesia at the time of sacrifice. 
Samples were drawn into heparin sodium (CP Pharmaceuticals, Wrexham, 
Wrexham County), 40 U⋅ml-1 blood, and were centrifuged at 1,600g for 10 min. 
The plasma supernatant was then collected and frozen at -80ºC. 
 
For quantitative RT-PCR experiments, mesentery extending from the Treitz 
ligament to the terminal ileum was excised off the bowel along its connection. 
Then the whole piece of mesentery with the enclosed main trunks and branches 
of the mesenteric artery and vein was excised and submersed immediately into 
excessive volume (~5 ml) of RNAlater RNA-stabilization solution (Ambion, 
Warrington, Cheshire), which works by preserving the quality and quantity of 
RNA through inactivation of RNase, the enzyme that degrades RNA. The 
thoracic aorta was freed from the surrounding tissue and inferior vena cava 
while in situ, and then excised and submersed immediately into RNAlater 
reagent. The tissue samples were kept at 4ºC overnight. The next day, the main 
trunk and branches of mesenteric artery were isolated by dissecting away the 
surrounding tissue and veins in ice-cold RNAlater reagent. The media layer of 
the aorta was stripped off the adventitial layer, which after the overnight 
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incubation in the RNAlater reagent at 4ºC became easy to perform. The 
mesenteric artery and aorta samples were then removed from the RNAlater 
reagent and kept in -80ºC until further experiments. This method has previously 
been shown to be able to preserve high-quality RNA and protein in tissue 
samples (Rodrigo et al., 2002). 
 
For measuring vascular KATP channel functional activity, thoracic aortae and the 
main-trunk mesentery arteries were excised and freed of connective tissue in 
ice-cold Krebs buffer (in mM: NaCl 120, KCl 5.9, NaHCO3 15.5, NaH2PO4 1.2, 
CaCl2 2.5, MgCl2 1.2, and glucose 11.5). These vessels were then immediately 
used in the rubidium-86 (86Rb+) experiments as described in 2.5.2. 
 
2.3. Nitrite determination 
Nitrate and nitrite (collectively referred to as NOx) are stable metabolites of NO, 
and their levels in the cell culture medium and animal plasma can serve as a 
surrogate marker of NO production. As nitrite in whole blood is rapidly 
converted to nitrate in the erythrocyte (Kelm, 1999), plasma nitrate needs to be 
reduced to nitrite to fully reflect NOS activity in vivo before measuring nitrite 
levels using the Griess reaction (detailed below). In contrast, in cell culture 
medium NO is oxidized almost completely to nitrite given the high oxygen 
tension in the atmosphere; therefore, the nitrate reduction step was omitted in 
these in vitro studies. 
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2.3.1. Reduction of serum nitrate to nitrite 
The nitrate reduction steps were adapted from Tracey (Tracey et al., 1995). 
Briefly, plasma samples were filtered through a 1.2-µm Multi-screen filter plate 
(Millipore, Watford, Herts). In each individual well of a 96-well plate, 6 µl of 
plasma was mixed with 44 µl of distilled water, 20 µl of 0.31 M potassium 
phosphate buffer (pH 7.5) and 10 µl each of 0.86 mM nicotinamide adenine 
dinucleotide phosphate, 0.11 mM flavin adenine dinucleotide and 1.0 units⋅ml-1 
of nitrate reductase (derived from Aspergillus species, activity 0.4 units⋅mg-1; 
Roche, Mannheim, Germany). Samples were then incubated for 1h at room 
temperature in the dark, before performing the Griess assay. Recovery of 
nitrate was >95% and the assay results were not significantly affected by the 
presence of plasma proteins. 
 
2.3.2. Griess Reaction 
The Griess reaction is based on a nitrite-dependent diazotization and azo 
coupling to produce a coloured azo compound in a concentration-dependent 
manner (Ivanov, 2004). By adding in acidified sulphanilamide and N-1-
naphthylamine to nitrite-containing fluid, the coloured azo compound can thus 
be generated, of which the concentration can be measured colorimetrically. 
 
To determine the nitrite level in the cell culture medium, RASMC were cultured 
in triplicate in 12-well culture plates at a density of 2 × 104 cells per well, 
suspended in 1 ml of DMEM/Ham’s F-12 containing 0.4% FBS (low endotoxin), 
50 units⋅ml-1 penicillin, and 50 µg⋅ml-1 streptomycin. At various time points, with 
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or without inflammatory mediators and/or 1400W, 50 µl of medium was 
collected and allowed to react with 50 µl each of 0.1% (w/v) sulphanilamide in 
3N HCl and 0.01% (w/v) naphthylethylenediamine dihydrochloride for 10 min at 
room temperature in the dark. The absorbance at 560 nm was measured with a 
spectrophotometer (GENios, Tecan, Reading, Berks). Nitrite concentrations 
were determined using sodium nitrite (0.5-50 µM in cell culture medium) as a 
standard (Figure 2.2). All measurements were done in triplicate. 
 
To determine the plasma NOx level, samples first went through the nitrate 
reduction steps, as detailed in 2.3.1. These steps turned 6 µl of samples into 
100 µl of solution, which was allowed to react with 50 µl each of sulphanilamide 
and naphthylethylenediamine, and the absorbance at 560 nm was then 
measured in the same manner as mentioned above. Nitrite concentrations were 
determined using sodium nitrite (2.5-250 µM) as a standard. All measurements 
were done in triplicate. 
 
2.3.3. Protein determination using the Lowry method 
To normalize nitrite concentration for tissue mass, the protein content of the 
cells was measured. Cells in each well were dissolved in 0.5% NaOH overnight 
at room temperature, and the Bio-Rad DC Protein Assay (Bio-Rad, Hercules, 
CA, USA) kit used to determine protein content as per manufacturer’s 
instructions. Absorbance at 720 nm was measured by spectrophotometry 
(GENios, Tecan). Protein concentrations were determined using BSA (0.5-1.5 
mg·ml-1) as the standard (Figure 2.3). 
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Figure 2.2. The standard curve for the Griess nitrite assay. The nitrite standard 
curve was prepared by serially diluting sodium nitrite in cell culture medium to the 
desired concentration (n = 3). Changes in absorbance according to nitrite concen-
trations fitted with linear regression. 
 
 
Figure 2.3. The standard curve for the BioRad protein assay. The protein standard 
curve was prepared by dissolving and serially diluting bovine serum albumin (BSA) in 
0.5% NaOH to the desired concentration (n = 3). Changes in absorbance according to 
BSA concentrations fitted with linear regression. 
R = 0.99895 
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2.4. Molecular biology and biochemistry 
2.4.1. Tissue homogenization and total RNA extraction 
Frozen samples of rat aorta and mesenteric artery were pulverized into powder 
using a pre-chilled metal pestle and mortar. Before each pulverization the pestle 
and mortar were cleaned and wiped with RNase AWAY Reagents (Invitrogen, 
Paisley, Renfrew) to prevent cross-contamination. After pulverization, the tissue 
powder was carefully collected into a pre-chilled, RNase-free microcentrifuge 
tube, making sure the powder was not thawed. 
 
For total RNA extraction, each sample of tissue powder was suspended in 1 ml 
of TRIzol reagent (Invitrogen). The suspension was then vortexed vigorously for 
2 min, and then removed to a QIAshredder Spin-Column Homogenizer (Qiagen, 
Crawley, West Sussex). The column was centrifuged at 16,000g for 2 min at 
4ºC in a benchtop microcentrifuge (Model 5415R, Eppendorf, Histon, 
Cambridge) and the flow-through removed to a pre-spun Phase Lock Gel 
Heavy tube (Eppendorf), into which 200 µl of chloroform was subsequently 
added. The tube was then manually shaken vigorously for 15 sec and then 
allowed to incubate at room temperature for 2-3 min; then it was centrifuged for 
5 min at 12,000g and 4ºC to separate the phases. The aqueous phase (~450 µl 
in volume) was removed to an RNase-free microcentrifuge tube into which five-
sixth volume (~375 µl) of propran-2-ol (Sigma-Aldrich) was added. The tube 
was then vortexed, and the mixture removed to an RNeasy Mini Spin Column 
for subsequent total RNA extraction using the RNesay Mini RNA extraction kit 
(Qiagen, Crawley, West Sussex), as per manufacturer’s instructions (see 2.4.2). 
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Using this procedure, a typical thoracic aorta and mesenteric arterial bed 
yielded approximately 12-18 µg and 5-8 µg of RNA, respectively. 
 
2.4.2. Cell homogenization and total RNA and protein extraction 
For total RNA extraction, RASMC were scraped off the bottom of the T-75 flask 
in the presence of 600 µl Buffer RLT from the RNeasy Mini kit. The cell 
suspension was vortexed, and then removed to a QIAshredder Spin-Column 
Homogenizer. The column was centrifuged at 16,000g in a benchtop 
microcentrifuge (Model 5415R, Eppendorf) for 2 min at 4ºC, and the flow-
through collected for total RNA extraction using RNeasy Mini kit as per 
manufacturer’s instructions. Briefly, ethanol was added to the flow-through to 
facilitate the binding of the RNA molecules to the resin in the RNeasy Mini Spin 
Column. Genomic DNA, small RNA and protein were subsequently washed 
away with two buffers. RNA of size >200 nucleotides was then eluted from the 
Spin Column with diethylpyrocarbonate (DEPC)-treated water. 
 
The amount of total RNA obtained from each sample was quantified by 
measuring absorbance at 260 nm (A260) of the RNA solution with a 
spectrophotometer (ND-1000, NanoDrop Technologies, Wilmington, DE, USA). 
Each unit of change in the absorbance value at A260 compared to blank solution 
represents a RNA concentration of 40 ng⋅µl-1. Absorbance at 280 nm (A280) 
arises from contaminating proteins, and an A260/A280 ratio >1.8 indicates 
adequate quality of RNA. In the current set of experiments, all samples used 
had an A260/A280 ratio >1.97. 
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For protein extraction for Western blotting, RASMC were scraped off the bottom 
of the T-75 flask in the presence of 100 µl lysis buffer (in mM: Tris⋅HCl [pH 7.5] 
50, ethylene glycol tetraacetic acid 2, DTT 0.5, phenylmethylsulphonyl fluoride 
1, Na3VO4 1; to every 10 ml of buffer add a Complete Mini Protease Inhibitor 
Cocktail Tablet [Roche Biologicals, Burgess Hill, West Sussex]). The cell 
suspension was removed to a QIAshredder Spin-Column Homogenizer and 
centrifuged at 16,000g and 4ºC in a benchtop microcentrifuge (Model 5415R, 
Eppendorf) for 2 min; the flow-through was collected and kept in -80 ºC. A small 
aliquot was collected for protein measurement using the BCA Protein Assay 
(Novagen, Beeston, Nottingham) kit as per manufacturer’s instructions. 
Absorbance at 560 nm was measured by a plate reader (GENios, Tecan). 
Protein concentrations were determined using BSA (20-1,000 µg⋅ml-1) as the 
standard (Figure 2.4). 
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Figure 2.4. The standard curve for the BCA protein assay. The protein standard 
curve was prepared by serially dilutin bovine serum albumin (BSA) solution to the 
desired concentration (n = 3). Changes in absorbance according to BSA concentra-
tions fitted with linear regression. 
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2.4.3. Reverse transcription into complementary DNA 
For cell samples, 5 µg of RNA was used to synthesize complementary DNA 
(cDNA) using oligo-deoxythymidine primer (oligo-d(T)12-18; New England 
Biolabs, Hitchin, Herts) and SuperScript II RT reverse transcriptase kit 
(Invitrogen) in a 20 µl reaction as per manufacturer’s instructions. One-tenth of 
the product of RT reaction was used as the template for conventional PCR. For 
tissue samples, 3 µg RNA for aortae and 1 µg for mesenteric arteries were used 
to synthesize cDNA using oligo-deoxythymidine primer (oligo-d(T)20; Invitrogen) 
and SuperScript III RT reverse transcriptase kit (Invitrogen) in a 20 µl reaction 
as per manufacturer’s instruction. The cDNA products were diluted with DEPC-
treated water into 1/30× solution for aorta and 1/10× solution for mesenteric 
artery samples; 2 µl was used for each of the triplicates as the template for 
quantitative PCR. 
 
2.4.4. PCR and real-time quantitative PCR 
PCR were set up as 50 µl reactions containing 0.5 unit of Taq DNA polymerase 
supplied with ThermoPol Buffer (New England Biolabs), 25 pmol of the forward 
and reverse primers, 10 nmol of deoxynucleoside triphosphates (dNTPs), and 2 
µl of cDNA synthesized from the previous 20 µl RT reaction. The sequences of 
the oligonucleotide primers (Sigma-Genosys, Haverhill, Suffolk) were: KIR6.1 
(Kcnj8, accession number: NM_017099) forward 5’-CAC AAG AAC ATC CGA 
GAG CA-3’, and reverse 5’-TGG AGA AGA GAA ACG CAG AAG-3'; SUR2B 
(Abcc9, accession number: NM_013040) forward 5’-CCA AGA ACC TCC ACC 
ACA A-3’, and reverse 5’-TCA TCC CAA TAG CCG ACA-3'. The primer 
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sequences for KATP channel subunits were designed using Primer3-web 
software, version 0.3.0 (http://frodo.wi.mit.edu /primer3/input.htm; (Rozen and 
Skalesky, 2000). All primer sets are intron-spanning. PCR was performed using 
an automated thermal cycler (Dyad PTC-220, MJ Research, Dunmow, Essex) 
under the following conditions: 92ºC for 1 min 15 sec, followed by 35 cycles at 
92ºC for 45 sec, 59ºC for 30 sec, and 72ºC for 1 min, and lastly by an extended 
elongation step of 72ºC for 10 min. PCR products were verified by 
electrophoresis on 2% Tris-acetic acid-EDTA agarose gel containing 1 µg⋅ml-1 
ethidium bromide and visualised under an ultraviolet lamp. Electrophoretic band 
intensity was quantified using ImageJ software, version 1.37 (National Institutes 
of Health, Bethesda, ML, USA), with respect to that of the housekeeping gene, 
β-actin (Actb, accession number: NM_001101), of which the primer sequences 
were forward 5’-GGC TAC AGC TTC ACC ACC AC-3’, and reverse 5’-TAC 
TCC TGC TTG CTG ATC CAC-3'. The amount of RT product in β-actin lanes 
was reduced to one-fourth, i.e. 0.5 µl of cDNA synthesized from the previous 
20-µl RT reaction was used to generate comparable signal intensity so as to 
facilitate comparison with bands of KATP subunit mRNA. The predicted sizes of 
the amplicons are: 265 base pairs (bp) for KIR6.1, 189 bp for SUR2B, and 497 
bp for β-actin. 
 
Real-time quantitative PCR (Heid et al., 1996) were set up in triplicate in white 
96-well plates (ABgene, Epsom, Surrey) as 20 µl reactions containing 10 µl of 
SYBR Green PCR Master Mix (Applied Biosystems, Warrington, Cheshire), 
cDNA from the previous RT reaction in the amount as described in 2.4.3, and 
the forward and reverse primers, of which the amounts are detailed below. 
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SYBR Green PCR Master Mix contains SYBR Green I dye, hot start AmpliTaq 
Gold DNA polymerase, dNTPs, and optimized buffer components. SYBR Green 
I is an asymmetrical cyanine dye that binds to double-stranded DNA (dsDNA). 
The resulting DNA-dye complex absorbs blue light (λmax = 497 nm) and emits 
green light (λmax = 522 nm), which is detected by the real-time PCR machine to 
measure the amount of dsDNA. At the concentrations used for real-time PCR,  
 
 
 
 
 
 
 
 
Figure 2.5. Determination of the threshold cycle (CT) value in a real-time 
polymerase chain reaction (PCR). Figures were generated from mathematical 
simulation. It assumes the presence of 109 copies of double-stranded DNA binding to 
SYBR Green I dye emits a fluorescence intensity of 1 unit and an amplification 
efficiency of the PCR to be 100%. The exponential increase in PCR products (the 
linear portion of the curves in the right panel, which is the same as the left panel except 
the y axis is of log scale) will not be detected until the accumulated PCR product 
binding to SYBR Green I reaches the amount that can emit fluorescence beyond the 
threshold level (indicated by the red lines). For a reaction that begins with 10 copies of 
template (closed circle), this event happens at cycle 24 (i.e., CT = 24.0), whereas for a 
reaction that begins with 1 copy of template (open circle), it happens between cycles 
27 and 28 (i.e., CT = 27.3). CT values can thus represent the template number in a 
given sample (Heid et al., 1996). Threshold is often automatically determined by the 
real-time PCR signal detection software, which often uses the fluorescence intensity 10 
times the standard deviation above the noise of the baseline. 
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free SYBR Green I or that bound to the single-stranded DNA emits very low 
background fluorescence, whereas SYBR Green I bound to dsDNA emits much 
stronger fluorescence of approximately 2,000 times the initial, unbound 
fluorescent signal when properly illuminated (Shipley, 2006). Real-time PCR 
reports the threshold cycle (CT) value as the quantitative measurement of the 
initial template amount in a reaction (Heid et al., 1996). Briefly, the lower the CT 
value, the more copies of template in the sample assayed (Figure 2.5). In RT-
PCR, it represents an increased transcriptional expression of the gene of 
interest yielding more mRNA. 
 
The sequences of the oligonucleotide primers (Sigma-Genosys) designed using 
Primer3-web software, version 0.3.0, were: KIR6.1 forward 5’-CGT CAC ACG 
CTG GTC ATC TTC -3’, and reverse 5’-TCA GTC ATC ATT CTC CCT CCA 
AAC C-3'; SUR2B forward 5’-GCG GAT CGC ACG GTT GT-3’, and reverse 5’-
CGA ACG AGG CGA ACA CTC CA-3'; and the reference gene, 
hydroxymethylbilane synthase (Hmbs, accession number: NM_013168) forward 
5’- CAC CTG GAA GGA GGC TGT AG-3’, and reverse 5’-CAG GTA CAG TTG 
CCC ATC CT-3'. All primer sets were intron-spanning. Hmbs was chosen to be 
the reference gene in this study as its expression appears to be unaltered by 
sepsis (Bilbault et al., 2004; Alamdari et al., 2008). The predicted sizes of the 
amplicons are: 242 bp for KIR6.1, 148 bp for SUR2B, and 69 bp for Hmbs. The 
annealing temperature and primer concentrations were optimized, and the 
calibration curve and amplification efficiency for each pair of primers were 
determined (Figure 2.6). Eight pmol of each primer is used in each reaction 
except for the reverse primers of KIR6.1 and Hmbs, for which 10 pmol was used. 
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Figure 2.6. Calibration curves and assay efficiency (E) of the real-time 
polymerase chain reaction. The calibration curves were constructed using serial 
dilutions of cDNA and their corresponding CT value determined. The assay efficiency is 
calculated based on the slope of respective curves: Efficiency = [10(-1/slope)] – 1. 
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Figure 2.7. Melting curve analysis of the real-time polymerase chain reaction 
(PCR) amplicons. A double-stranded DNA (dsDNA) molecule dissociates into two 
single-stranded DNA molecules at a specific temperature depending on its length and 
guanine-cytosine content. Through heating up the PCR product at a constant rate of 
increasing temperature and detecting the point of abrupt decrease in fluorescence 
emission (indicating massive dissociation of dsDNA molecules), the melting 
temperature can be determined. The figure showed the melting curves of 8 samples, 
each assayed in triplicate. The single peak for amplicons from each primer pair 
indicates that no primer-dimers were synthesized in the experiment. 
 
 
Real-time quantitative PCR was performed using an automated thermal cycler 
(Mastercycler ep realplex, Eppendorf) under the following conditions: 94ºC for 
10 min, followed by 40 cycles at 94ºC for 15 sec, 60ºC for 2 sec, and 72ºC for 
30 sec, followed by a melting curve analysis consisting of a linear increase in 
temperature from 60ºC to 95ºC in 20 min (Figure 2.7).The relative amount of 
the cDNA in relation to the reference gene (which normalizes the amount of 
template input) is calculated using the ‘delta-delta CT’ method corrected with 
KIR6.1 
SUR2B 
Hmbs 
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primer efficiency (Souazé et al., 1996). Briefly, the ratio of the cDNA amount of 
the target and the reference genes can be calculated using the equation: 
 
  
! 
ratio =
(Etarget )
"CT target (control#sample)
(ERef )
"CTRef (control#sample)
 
Etarget = assay efficiency of the target amplicon 
ERef = assay efficiency of the reference amplicon 
∆CTtarget(control – sample) = average CT of target amplicon in the control group – CT of 
target amplicon in individual samples 
 ∆CTRef(control – sample) = average CT of reference amplicon in the control group – CT 
of reference amplicon in individual samples 
 
Equation 2.2. Relative quantitation of the target amplicon with respect to the 
reference amplicon in a real-time polymerase chain reaction. 
 
 
Thus in this study, the ratio of KIR6.1/Hmbs and SUR2B/Hmbs cDNA amount 
can be calculated in both sham and septic animals. Provided the amount of 
reference gene cDNA is not altered by the experimental condition, i.e. in the 
current study Hmbs expression was not altered by the septic stimulus, the ratio 
of KIR6.1 and SUR2B cDNA amount between sham and septic animals can thus 
be calculated (Figure 2.8). 
 
PCR products were verified by electrophoresis on 2% Tris-acetic acid-EDTA 
agarose gel containing 1 µg·ml-1 ethidium bromide, and visualized under an 
ultraviolet lamp. The PCR amplicons were submitted for DNA sequencing 
(Scientific Support Services, Wolfson Institute for Biomedical Research, UCL) to 
ensure correct product generation. 
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Figure 2.8. Calculation of the mean fold change in KIR6.1 gene expression in 
aortae of sham and septic rats at 6h. Modified from Livak and Schmittgen (2001). 
 
 
2.4.5. Western blotting 
7.5% sodium dodecyl sulphate (SDS)-polyacrylamide gels were prepared and 
poured following standard recipes: stacking gel (7.5% acrylamide [Bio-Rad], 
0.1% (w/v) SDS [Fluka], 125 mM Tris [pH 6.8], 0.05% (w/v) ammonium 
persulphate, and 0.1% (v/v) N,N,N’,N’-tetramethylethylenediamine (TEMED)); 
resolving gel (7.5% acrylamide, 0.1% (w/v) SDS, 375 mM Tris [pH 8.8], 0.05% 
(w/v) ammonium persulphate, and 0.05% (v/v) TEMED). Prior to gel loading, 
cell homogenates were diluted in 6× loading buffer with a final concentration of 
1.7% (w/v) SDS, 58.3 mM Tris (pH 6.8), 100 mM DTT, and 5% (w/v) glycerol. 
Sample were mixed and heated to 95ºC for 15 min to denature proteins. Gels 
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were run in a standard running buffer containing 0.1% SDS, 25 mM Tris and 
192 mM glycine. Samples were fractionated at constant currents of 20 (in 
stacking gels) and 30 (in resolving gel) mA for every 1.5 mm-thick gel for 45 min 
until the dye front had run off the bottom of the gel. The gel was subsequently 
loaded onto a blotting apparatus and sample transferred to the polyvinylidene 
difluoride (PVDF) membrane (Immobilon-P, Millipore, Watford, Herts) in a 
transfer buffer containing 10 mM 3-(cyclohexylamino)-1-proprane sulphonic 
acid (CAPS; pH 11) and 10% methanol. The gel was allowed to transfer at 
constant voltage of 50 volts at room temperature for 30 min, and then the 
membrane was air-dried for 15 min after soaking in 100% methanol for 10 sec. 
The reason for using CAPS buffer instead of the routinely used Tris-glycine 
buffer is the possible high isoelectric point (pI) of the KIR6.1 protein. The 
computed theoretical pI is 9.35, calculated using the “Compute pI/Mw tool” 
website calculator (http://www.expasy.ch/tools/pi_tool.html; (Bjellqvist et al., 
1994) of the Swiss Institute of Bioinformatics’ ExPASy Proteomics Server 
(Gasteiger et al., 2003). The routinely used Tris-glycine buffer (pH 8.3) causes 
the KIR6.1 protein to migrate toward the opposite direction to where the PVDF 
membrane is, thereby resulting in failure of blotting and protein loss. 
 
For Western blotting, the Amersham ECL detection kit (GE Healthcare, Little 
Chalfont, Bucks) was used. Briefly, the air-dried PVDF membrane was wetted 
by soaking in 10% methanol for 15 sec and then in Milli-Q water (Millipore) for 2 
min. It was then incubated at room temperature for 60 min in the blocking agent 
that consists of 10% non-fat dried milk dissolved in Tris-buffered saline (100 
mM Tris⋅Cl [pH 7.5] in 0.9% (w/v) NaCl) containing 0.1% (w/v) Tween 20 (TBS-
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T). The primary antibody, either goat anti-KIR6.1 (R-14) (diluted 1:500) or goat 
anti-SUR-2B (C-15) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) (diluted 
1:200) was added into the blocking agent and incubated with the blot for 60 min 
at room temperature with agitation. This was followed by 3 × 15 min washes 
with TBS-T. The secondary antibody (horseradish peroxidase-conjugated rabbit 
anti-goat IgG; Santa Cruz) was diluted 1:10,000 in the blocking agent and 
incubated with the blot for a further 60 min at room temperature with agitation. 
This was again followed by 3 × 15 min washes with TBS-T. The detection 
reagent was constituted through mixing equal volumes of detection solution 1 
with detection solution 2. The reagent was then applied to the surface of the 
membrane, and the blots incubated for 1 min at room temperature. Excessive 
detection regent was then drained, and the fluorescence signals detected using 
autoradiography film. 
 
After signal detection, the same PVDF membrane was stained with Coomassie 
brilliant blue R (Bio-Rad) as per manufacturer’s instructions to normalize the 
quantity of protein loaded. Briefly, the membrane was incubated in a solution of 
0.1% Coomassie brilliant blue R in 50% methanol and 7% acetic acid for 2 min. 
It was de-stained in 50% methanol and 7% acetic acid for 10 min. The third step 
of de-staining in 90% methanol and 10% acetic acid for 10 min was not 
performed as this often leads to the excessive de-staining of the membrane. 
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2.5. Vascular KATP channel functional activity 
2.5.1. Membrane potential dye assay 
KATP channel functional activity was assessed using the membrane potential-
sensitive fluorescence dye bis-(1,3-dibutylbarbituric acid) trimethine oxonol 
(DiBAC4(3); Molecular Probes, Paisley, Renfrew) following a published protocol 
(Gopalakrishnan et al., 1999). DiBAC4(3) enters depolarized cells where it binds 
to intracellular proteins or membranes and exhibits enhanced fluorescence. 
Increased depolarization results in more influx of the anionic dye, leading to an 
increase in fluorescence. Hyperpolarization results in extrusion of the dye and a 
decrease in fluorescence (Apell and Bersch, 1987). Briefly, RASMC were plated 
out onto 96-well black clear-bottomed plates at a density of 2 × 104 cells per 
well using a total volume of 200 µl, and were grown in DMEM/Ham’s F-12 
supplemented with 10% FBS, 50 U⋅ml-1 penicillin and 50 µg⋅ml-1 streptomycin. 
Upon reaching confluence on about Day 3 or 4, cells were serum-starved for 
48h before being treated with LPS and IL-1β for 48h. 
 
Upon treatment completion, cells were rinsed twice with 200 µl of assay buffer 
(in mM: NaCl 120, KCl 2, CaCl2 2, MgCl2 1, glucose 5, HEPES 20, 
tetraethylammonium [TEA] 1, pH 7.4 at 25°C) containing 5 µM DiBAC4(3). TEA 
was added at this concentration so as to inhibit BKCa channel activity, a major 
K+ conductance in smooth muscle (Clapp and Gurney, 1991; Clapp and Tinker, 
1998). Following this procedure, cells were incubated with 180 µl of the same 
DiBAC4(3)-containing buffer for at least 30 min in a cell incubator at 37ºC and 
95% air/5% CO2. The 96-well plates were then moved to a fluorescent imaging 
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plate reader (FLIPR; Schroeder and Neagle, 1996; Molecular Devices, Paisley, 
Renfrew). Assays were carried out at 37ºC, being initiated by addition of 20 µl 
of a 10× concentration of Lev at different test concentrations prepared in the 
assay buffer containing 5 µM DiBAC4(3). Changes in fluorescence were 
monitored for 25 min by sampling every 30 sec from 96 wells simultaneously, at 
excitation and emission wavelengths of 488 and 520 nm, respectively. The 
absolute value of the maximal levcromakalim-evoked change in fluorescence 
(∆F) for each well was normalized to the background fluorescence (F). Changes 
in fluorescence are thus shown as ∆F/F. 
 
2.5.2. Rubidium efflux 
The radioisotope rubidium-86 (86Rb+) has been widely used in many tissues as 
a surrogate marker for K+ efflux/loss from cells (e.g. Bolton and Clapp, 1984). It 
is more convenient to use than 42K+ due to its much longer half-life (19 days 
versus 12h). Aortae and main trunk mesenteric arteries preserved in ice-cold 
Kreb’s buffer (see 2.2.3) were carefully cut into two pieces along their 
longitudinal axis. The endothelium was gently removed through rubbing with a 
cotton swab. The arterial strips were then incubated in DMEM/Ham’s F-12 
containing 86Rb+ (0.037 MBq⋅ml-1) for 3h to reach equilibrium of loading (Bolton 
and Clapp, 1984). The loading medium was then removed, and the arterial 
strips washed three times with assay buffer (in mM: NaCl 136.8, KCl 5.4, CaCl2 
1.8, MgCl2 0.5, MgSO4 0.4, NaHCO3 2.5, NaH2PO4 0.65, KH2PO4 0.44, glucose 
5.5, HEPES 7.5, TEA 1) to remove excess 86Rb+. Each arterial strip was then 
placed in a well of a 6-well plate, and 2 ml of assay buffer added to each well. 
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One ml of buffer was immediately collected to determine the background value, 
and the other ml was removed 15 min later to determine the amount of baseline 
86Rb+ efflux. Another 1 ml of assay buffer containing 10 µM of levcromakalim 
was then added to each well and removed 15 min later to determine the 86Rb+ 
efflux in response to vascular KATP channel opening. The amount of radioactivity 
in each sample/supernatant was measured by Packard 2000CA Tri-Carb liquid 
scintillation analyzer (Packard Instruments, Cambridge, Cambridge) and 
normalized to the total amount in the blood vessel at that time. 
 
2.6. Chemicals 
All in vitro drugs were prepared and diluted in water, unless otherwise specified. 
Levcromakalim for use in vitro and DiBAC4(3) were dissolved in dimethyl 
sulphoxide (DMSO). The final concentration of DMSO in in vitro experimental 
solutions did not exceed 0.2% (v/v). All chemicals were purchased from Sigma-
Aldrich, except the following: IL-1β was purchased from R&D Systems; 
midazolam (midazolam hydrochloride) was from Roche (Welwyn Garden City, 
Herts); NE (norepinephrine tartrate) was from Abbott Labs; pentolinium was 
from Acros Organics (Morris Plains, NJ, USA); and PNU-37883A was from 
BIOMOL International (Exeter, Devon). All chemicals were of highest grade 
available. 
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2.7. Statistical analysis 
The number of experiments was chosen on the basis of previous similar 
experiments conducted in my host lab. A formal power calculation, from which 
the sample size needed to show statistically and clinically significant differences 
was, however, not performed. All figures are presented as mean ± standard 
error of the mean (S.E.M.) of n observations. Statistical analysis between two 
groups was performed using paired or unpaired Student’s t test, and between 
multiple groups using one-way analysis of variance (ANOVA). In vivo arterial 
pressures were compared between time-points and clinical groups using two-
way ANOVA (with repeated measures where appropriate). ANOVA values were 
corrected for comparisons against the control group (Bonferroni post-hoc test) 
or all groups (Newman-Keuls post-hoc test) using Prism 5.0 (GraphPad 
Software, La Jolla, CA, USA). In all analyses, a p value <0.05 was considered 
statistically significant. 
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Chapter Three Vascular KATP channel expression 
Chapter 3. Vascular KATP channel expression 
 
3.1. Introduction 
I began the project with an investigation of whether vascular KATP channel gene 
expression was influenced by septic stimuli, hypothesizing that the channel 
gene could be induced during sepsis, leading to an increase in channel number 
and thus channel activity. (Czaika et al., 2000) showed an increased expression 
of the pore-forming KIR6.1 subunit in the diaphragm of the endotoxemic rat. The 
authors did not assessed the change in channel activity. Later, in a model of 
murine experimental colitis, an increased transcriptional expression of KIR6.1 in 
colonic smooth muscle was associated with an increase in the whole cell 
current both basally and when stimulated by the KATP channel opener, 
levcromakalim (Jin et al., 2004). More recently, Shi et al. (2010) showed that 
murine aortae exposed in vitro to LPS (1 µg·ml-1) had an increase in both KIR6.1 
and SUR2B gene expression. This was accompanied by an increase in basal 
KATP current density. Thus sepsis may be able to induce an increase in channel 
gene expression that ultimately augments channel functional activity. However, 
to which extent does channel gene induction contribute to the increase in 
channel functional activity remains to be determined, as the former does not 
necessarily result in the composition of functioning channels (Crane and 
Aguilar-Bryan, 2004). Whether channel gene induction also appears in vivo also 
awaits confirmation. 
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3.2. KATP channel expression and activity in RASMC 
3.2.1. Cell viability 
Using the trypan blue dye exclusion method, the viability of RASMC subjected 
to a 48h treatment with LPS (1 µg·ml-1) and IL-1β (10 ng·ml-1) was found to be 
similar (97.8 ± 1.6%, n = 3) to control cells (97.5 ± 1.7%, n = 3; p = NS). Thus 
treatment itself did not appear cytotoxic or detrimental to cell survival. 
 
3.2.2. Nitrite levels in culture medium 
I first sought to determine if treatment of RASMC with a combination of LPS and 
IL-1β could induce NOS2 and generate excessive amounts of NO. In control 
RASMC, the nitrite level in the culture medium was 0.3 ± 0.2 µM at 24h, which 
rose to 1.0 ± 0.3 µM at 48h, though not significantly (n = 4). Upon treatment with 
LPS and IL-1β, the nitrite level profoundly increased ~30-fold to 9.2 ± 1.3 µM at 
24h, and ~15-fold to 15.4 ± 1.7 µM at 48h (p <0.01; Figure 3.1). For all 
subsequent experiments, I chose to incubate cells for 48h with inflammatory 
mediators, since the NO levels were substantially higher at this time point 
compared to 24h. 
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Figure 3.1. Effect of inflammatory mediators on nitrite production by cultured rat 
aortic smooth muscle cells (RASMC). Nitrite levels in the culture medium were 
measured following treatment of RASMC with lipopolysaccharide (LPS; 1 µg·ml-1) and 
interleukin (IL)-1β (10 ng·ml-1). Cells were serum-starved for 48h in culture medium 
before LPS and IL-1β were added for both 24 or 48h. **p <0.01 (two-way ANOVA with 
Bonferroni post-hoc test). 
 
 
Figure 3.2 shows nitrite levels in the cell culture medium harvested from cells 
receiving a septic stimulus with or without pre-treatment with the NOS2-
selective inhibitor, 1400W (10 µM). For control cells, the nitrite level was 1.8 ± 
0.2 µM·mg-1 protein (n = 6), and for 1400W-treated cells 2.6 ± 0.3 µM·mg-1 
protein (n = 4; p = NS vs. control). Nitrite levels in the cell culture medium were 
significantly higher for cells treated with LPS and IL-1β compared to control 
(34.9 ± 5.6 µM·mg-1 protein; n = 6; p <0.01), though no such increase (n = 4; p 
= NS vs. control) was observed in cells pre-treated with 1400W. 
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Figure 3.2. Effect of inflammatory mediators and the NOS2 inhibitor 1400W on 
nitrite production by cultured rat aortic smooth muscle cells (RASMC). Nitrite 
levels in culture medium harvested from quiescent RASMC incubated with 
lipopolysaccharide (LPS;1 µg·ml-1) and interleukin (IL)-1β (10 ng·ml-1) for 48h, with or 
without pre-treatment of 1400W (10 µM) were measured and normalized to cell protein. 
**p <0.01 (two-way ANOVA with Bonferroni post-hoc test). 
 
 
In summary, the dosage of 1 µg·ml-1 of LPS and 10 ng·ml-1 of IL-1β for 24 to 
48h induced RASMC to generate substantial amounts of NO, as determined by 
several fold increases in nitrite levels. 1400W effectively inhibited NO 
generation, suggesting NO was synthesized by NOS2 in this model. RASMC 
exposed to LPS and IL-1β at the above concentrations for 48h showed no 
change in cell viability. 
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3.2.3. RT-PCR 
I next wanted to establish whether the combination of LPS and IL-1β would 
change the transcriptional levels of KATP subunit genes. I firstly designed PCR 
primer sets and optimized the thermal cycle protocol and cycle number. I then 
tested the primers on control RASMC, and finally the treated these cells to see 
if I could detect differences in KATP subunit gene transcription. Representative 
results of RT-PCR from serum-starved RASMC cells in the absence and 
presence of inflammatory mediators are shown in Figure 3.3. In LPS and IL-1β 
treated RASMC there were higher levels of KIR6.1 subunit expression compared 
to untreated cells. When corrected for β-actin expression, the electrophoretic 
band intensity for KIR6.1 was 6.6-fold higher than that of control (p <0.05, n = 5; 
Figure 3.4).  
 
 
 
Figure 3.3. Inflammatory mediators increase expression of KIR6.1 in rat aortic 
smooth muscle cells (RASMC). Reverse transcription polymerase chain reaction 
analysis of KIR6.1 and SUR2B subunits from mRNA isolated from RASMC treated 
using the protocol described in 2.1.3. Amplified fragments (35 cycles) were electro-
phoresed on a 2% agarose gel. Lane one contains base pair markers and subsequent 
odd number lanes contain no reverse transcriptase. Visible products were detected for 
KIR6.1 (lanes 2 and 4; 265 bp), SUR2B (lanes 6 and 8; 189 bp) and the housekeeping 
gene β-actin (lanes 10 and 12; 497 bp). 
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As iNOS activity appears important in mounting inflammatory responses and 
sustaining the NF-κB signaling pathway (Hierholzer et al., 1998; van't Hof et al., 
2000), it may also contribute to the enhanced KIR6.1 gene expression in the 
current experiment. I therefore measured the amount of subunit mRNA in cells 
pre-treated with 1400W. The enhanced KIR6.1 expression induced by a 
combination of LPS and IL-1β was largely reversed by 1400W (band intensity 
187 ± 47%, p = NS vs. control, n = 4). In contrast, there was no change in 
SUR2B band intensity with the inflammatory mediators (97 ± 7%, n = 5), nor did 
1400W have any effect on SUR2B expression either (n = 4, p = NS). 
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Figure 3.4. Electrophoretic band intensity of reverse transcription polymerase 
chain reaction amplicons of KATP channel subunits. Band intensity was 
normalized to the housekeeping gene, β-actin, and was referenced to that of 
control cells. Quiescent RASMC were either left untreated or incubated with 
lipopolysaccharide (LPS; 1 µg·ml-1) and interleukin (IL)-1β (10 ng·ml-1) for 48h, without 
or with the selective iNOS inhibitor, 1400W (10 µM). 1400W was given since 1h before 
and remained throughout the whole period of LPS and IL-1β treatment. **p <0.01 (two-
way ANOVA with Bonferroni post-hoc test). 
 
 86 
Finally, the RT-PCR amplicons corresponding to KIR6.1 and SUR2B were cut 
out of the gel for sequencing (Scientific Support Services, WIBR, UCL) and 
were found to be identical with the reference sequences (KIR6.1 mRNA RefSeq 
accession number: NM_017099; SUR2B mRNA RefSeq accession number: 
NM_013040). 
 
3.2.4. KATP channel functional activity 
I then investigated whether changes in KATP functional activity corresponded to 
changes in KATP subunit gene expression. I used the membrane potential-
sensitive fluorescence dye DiBAC4(3) to assess the response of treated 
RASMC to the KATP channel opener, levcromakalim (Lev). More KATP channels 
in the plasma membrane ought to represent a larger change in ∆F/F at a given 
concentration of Lev. 
 
Lev caused a decrease in fluorescent intensity (Figure 3.5a), consistent with the 
agent causing membrane hyperpolarization (Gopalakrishnan et al., 1999). 
However, the changes in fluorescent intensity were not readily apparent until 
the concentration of Lev in the assay buffer reached 1 µM and above (Figure 
3.5b). Compared to control cells, significantly larger changes in fluorescence 
intensity were induced by Lev at 1 to 3 µM in RASMC subject to septic stimuli. 
Conversely, for 1400W pre-treated cells, the effect of septic stimuli was 
reversed (Figure 3.5a and b). When RASMC were stimulated by 3 µM Lev, the 
change in fluorescence (5,968 ± 447 fluorescent units for control, and 8,211 ± 
547 units for LPS and IL-1β-stimulated cells; n = 4, p <0.05) was compatible  
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Figure 3.5. Changes in fluorescent intensity in response to levcromakalim (Lev) 
for rat aortic smooth muscle cells incubated with lipopolysaccharide (LPS; 1 
µg·ml-1) and interleukin (IL)-1β (10 ng·ml-1) for 48h, with or without pre-treatment 
of the NOS2-selective inhibitor, 1400W (10 µM). Changes in fluorescent intensity 
(∆F) were normalized to background fluorescence (F). a) time-dependent changes in 
fluorescent intensity. Lev was added at 5 min (n = 4); b) changes in fluorescent 
intensity at increasing concentrations of Lev in assay buffer. The final 3 readings (at 30 
min) of each experiment were averaged to represent the ∆F/F of the experiment. n = 4; 
*p <0.05, **p <0.01 (two-way ANOVA with Bonferroni post-hoc test). 
a 
b 
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with that found in bladder smooth muscle cells (Gopalakrishnan et al., 1999), 
but the ∆F/F in RASMC seemed less (1,562 ± 34 fluorescent units for control, 
and 2,755 ± 312 units for LPS and IL-1β-stimulated cells; n = 4, p <0.05) 
compared to bladder smooth muscle cells (in the vicinity of 4,500 fluorescent 
units) when stimulated by 1 µM Lev. I did not derive the EC50 value in current 
study because higher doses of Lev were not tested and thus it is not clear that 
changes in ∆F/F had reached a maximum level. Nevertheless, it would surely 
be higher than the 0.4 ± 0.01 µM reported by Gopalakrishnan et al. (1999). 
 
3.3. KATP channel expression and activity in ex vivo arterial blood 
vessels from rats with peritonitis 
After establishing presence of increased KATP subunit gene expression in 
RASMC receiving septic stimuli and the corresponding increase in KATP channel 
activity, I continued to survey if the same phenomenon also occurred in vivo. I 
used a rat model of faecal peritonitis that has been well characterized in the 
host lab and mimics many of the clinical features of sepsis (Brealey et al., 2004; 
Barrett et al., 2007a). Further demonstration of its characteristics, including NO 
production, evidence of hypoperfusion, and effects of fluid resuscitation will be 
provided in the next chapter. Using this experimental model I collected aortae 
and mesenteric arteries and measured levels of KATP subunit gene expression 
using quantitative RT-PCR. 
 
I had to overcome a number of hurdles in order to successfully carry out the 
quantitative RT-PCR experiments, which proved time consuming. Firstly, to 
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avoid mRNA degradation from delayed or inappropriate tissue preservation, I 
initially chose to snap-freeze aortae in liquid nitrogen immediately after the 
animal was sacrificed. To do so, I needed to free the artery from the 
surrounding tissue in situ. This proved not too difficult if the vessel in question 
was the thoracic aorta. However, when it came to the mesenteric artery, it was 
impossible to complete the task in reasonably short time unless I only cut off 
and collected the main trunk. This limited mass of the mesenteric artery could 
only yield a small amount of RNA, and its ability to represent a resistance artery 
is called into question. Moreover, with snap-freezing method, I could not 
separate the media layer of aorta from the adventitial layer, which may 
confound the result because this layer may also expresses KATP channels. 
However, this method was later substituted by one utilising the RNAlater 
reagent which is capable of preserving high-quality RNA (Rodrigo et al., 2002). 
It proved invaluable because it allowed the collection of a greater mass of the 
mesenteric arterial bed, as well as the isolation of the media layer of aortae. 
 
Secondly, the extraction of RNA from aortic smooth muscle was problematic. I 
encountered difficulties in tissue homogenization and cell disruption, and 
therefore in the first instance could not obtain adequate amount of RNA from 
aortic samples. In my hand, the commercial kit (RNeasy Fibrous Tissue Mini kit, 
Qiagen) that recruits proteinase K to digest contractile proteins and collagen 
present in aortae, did not increase RNA yield. Subsequently, I found that TRIzol 
reagent in combination with the RNeasy Mini RNA extraction kit (Qiagen) was 
able to constantly provide satisfactory RNA yield from aortic samples. This 
combination also allowed convenient handling of the aqueous phase of TRIzol-
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chloroform mixture in the RNA extraction protocol. RNeasy Mini columns bind 
and protect RNA from loss during propran-2-ol precipitation and resuspension 
steps, and the chances of introducing RNase contamination would therefore be 
less. However, the suggested on-column DNase digestion step was not 
performed because of concerns of lowering RNA yield. Nevertheless, results of 
the real-time quantitative PCR were not affected by genomic DNA 
contamination as the melting curve analysis of PCR products showed that only 
a single kind of amplicon was generated for each primer pair. As the primers 
were specifically designed to span introns, they should have generated 
amplicons of different sizes depending on whether the template was mRNA or 
genomic DNA. 
 
The third issue in this set of experiments was the choice of reference gene. 
Housekeeping genes like Gapdh (coding for glyceraldehyde 3-phosphate 
dehydrogenase [GAPDH]) and Actb (coding for β-actin) are genes commonly 
used as the internal reference; their expression is thought to be relatively 
constant in response to a whole host of cellular interventions. However, this 
notion is not necessarily true for septic stimuli as previous studies have shown 
that the expression of these two ‘housekeeping’ genes can be unstable 
(Hagihara et al., 2004; Wang et al., 2010). Hajihara et al. (2004) showed 
variable levels of Gapdh and Actb expression after stimulation of human 
hepatoblastoma and hepatoma cell line with pro-inflammatory cytokines. In 
contrast, several studies have shown that another reference gene, Hmbs, was 
more stably expressed during sepsis (Bilbault et al., 2004; Alamdari et al., 
2008). While I found this also to be true in my hands, this may not always be 
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the case since expression of Hmbs is suppressed by hypoxia-inducible factor 
1α (Vargas et al., 2008). I did consider using 18S ribosomal RNA as the internal 
control in this study. Aside from the huge difference in amount between 
ribosomal and messenger RNA and the possible variation in their respective 
fractions between individual samples (Bustin and Nolan, 2004), it requires 
random hexamer for cDNA priming, which may lead to the synthesis of more 
than one copy of cDNA from a single mRNA template (Zhang and Byrne, 1999) 
and thus lead to nonspecific amplification.  
 
3.3.1. Quantitative RT-PCR 
At 6h, faecal peritonitis did not induce a significant increase in the vascular KATP 
subunit genes in aortae. On the contrary, SUR2B gene expression was 
suppressed (p <0.05; n = 5) in aortic smooth muscle. In mesenteric arteries at 
the same time point, there was an increase in KIR6.1 mRNA, but this change did 
not reach statistical significance. However, at 24h after the onset of faecal 
peritonitis there was a 4-fold increase in KIR6.1 gene expression, although 
SUR2B gene expression surprisingly remained unaltered (Figure 3.6). Thus the 
results in mesenteric arteries mirrored what I found in the primary cell culture 
model. At this stage, it is not clear why no such regulation was observed in 
aortae in vivo, but this will be further discussed later. 
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Figure 3.6. Real-time quantitative reverse transcription polymerase chain 
reaction of the vascular KATP channel subunit mRNA in the thoracic aorta and the 
mesenteric artery of rats subject to faecal peritonitis for 6 and 24h. KATP channel 
subunit mRNA was normalized to that of the housekeeping gene, Hmbs (coding for 
hydroxymethylbilane synthase). *p <0.05, **p <0.01 (two-way ANOVA with Bonferroni 
post-hoc test). 
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3.3.2. KATP channel functional activity 
In my earlier experiments, LPS and IL-1β caused KATP channel hyperactivity in 
RASMC despite only KIR6.1 subunit expressing being induced. Now that the 
same phenomenon occurred in ex vivo mesenteric arteries (but not in aortae) 
from septic rats, would these tissues also demonstrate KATP channel 
hyperactivity? In fact, if KATP channel basal hyperactivity could be detected in 
arterial tissues from septic animals, it would be the direct evidence that supports 
the channel’s involvement in sepsis-induced vascular changes. Therefore KATP 
channel activity was measured in these tissues using 86Rb+ efflux as a 
surrogate marker for K+ efflux (Bolton and Clapp, 1984). In each tissue, basal 
efflux of 86Rb+ was measured for 15 min, then 10 µM of Lev was added to the 
assay buffer to see if it would stimulate efflux of the radioisotope. An increase in 
the response to a maximal dose of the KATP channel opener might reflect either 
an increase in the number of channels present in the plasma membrane or an 
increase in the open probability of the channel. 
 
Figure 3.7 shows the results of the 86Rb+ efflux experiment. Basal efflux from ex 
vivo vessels from septic rats was not increased at either 6h or 24h time point for 
the two blood vessel types. However, Lev-induced efflux was significantly 
increased at 24h in both aortae and mesenteric arteries, but not at 6h. In sham 
rats there was a trend towards a decrease in 86Rb+ efflux evoked by Lev in 
aortae with time; no such trend was observed in mesenteric arteries. 
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Figure 3.7. Basal and levcromakalim (Lev)-stimulated 86rubidium (86Rb+) efflux 
(%) in aortae and mesenteric arteries taken from sham-operative control and 
septic rats subject to faecal peritonitis for 6 and 24h. Bars represent percentage of 
efflux over 15 min normalized to total amount of 86Rb+ in the blood vessel (Upper and 
middle panels). Change (∆) in 86Rb+ efflux (%) as induced by 10 µM Lev (Lower panel). 
*p <0.05 (two-way ANOVA with Bonferroni post-hoc test). 
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3.4. Channel proteins 
Questions arose from the results of the aforementioned experiments. The first 
concerns the non-paralleled changes in gene expression between the two 
channel subunits induced by septic stimuli, which occurred in both cultured 
primary cell and ex vivo tissue models. Thus whether an increase in gene 
expression of only the KIR6.1 subunit can lead to channel hyperactivity is not 
clear. In other words, was channel hyperactivity observed in RASMC and 
mesenteric arteries actually originating from their increased subunit 
transcriptional expression? Channel gene transcription and translation do not 
necessarily lead to composition of functioning channels, and it may well be that 
the number of channels that are induced by sepsis does not correlate well with 
the level of transcriptional expression. For KIR6.2/SUR1 KATP channels, the 
newly synthesized KIR subunit protein rapidly gets degraded if not combined 
with the SUR subunit (Crane and Aguilar-Bryan, 2004). Thus an increase in 
KIR6.1 transcriptional expression does not necessarily lead to a proportional 
increase in channel hyperactivity. 
 
The second question arose from the observation that the stimulated 
hyperactivity of the channel in ex vivo aortae from 24h septic animals was not 
associated with an increase in channel gene expression. A single arterial 
smooth muscle cell has ~100-500 KATP channels, and normally very few of them 
remain in open state at a given time (Nelson and Quayle, 1995). Such a low 
“open-state probability” (Po) is likely to result from inhibition of the channel by 
intracellular ATP, of which the physiological concentration is in the millimolar 
range (Kajioka et al., 1991; Quayle et al., 1994). Suppose 10 in 500 KATP 
 96 
channels remain open at a given time as the basal state (Po = 0.02). The 
opening of one additional channel is equivalent to the synthesis of additional 
500. Why would the body choose to mobilize the whole channel-synthesizing 
mechanism to produce 500 new channels instead of opening just one amongst 
the 500 channels that are already there? 
 
To answer these questions, it is important to determine the actual number of 
channels in plasma membrane, and the amount of channel proteins in a cell. 
Only then can channel gene expression and formation of functioning channels 
be correlated. I sought to measure the amount of subunit proteins in whole cell 
proteins as well as membrane fraction using Western blotting, hoping that I 
could demonstrate differences in protein production and plasmalemmal channel 
number. 
 
Unfortunately, I encountered problems with the setup of Western blot 
experiment, and as a result this part of the study was unsuccessful. The first 
problem was separating membrane fraction of proteins. I employed the method 
devised by Kwan et al. (1984) to separate proteins extracted from aortic smooth 
muscle, but could not obtain an amount sufficient for Western blot. Then I went 
back to RASMC and started with crude cell homogenate, only to realize that a 
very high amount of whole-cell protein (50 µg per lane) is needed to show a 
visible SUR2B band on the blot. This suggested that using Western blot to 
detect channel subunit proteins in membrane fraction of proteins would be very 
difficult, given there would be substantially less protein in membrane fraction. 
Despite these difficulties, Zhou et al. (2007) have managed to generate blot for 
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SUR2B using 10 µg membrane protein using an anti-SUR2B antibody they 
generated themselves.  
 
The second problem lies in the antibodies for KATP channel subunits used. The 
ability of the anti-SUR-2B (C-15; Santa Cruz) to bind specifically to SUR2B 
without cross-reaction with SUR2A remains doubtful given the close homology 
between these two splice variants. Moreover, the anti-KIR6.1 (R-14; Santa Cruz) 
was shown to actually bind to two mitochondrial proteins (NADP-
dehydrogenase flavoprotein 1 and isocitrate dehydrogenase) rather than KIR6.1 
(Foster et al., 2008). Morrissey et al. (2005) also found that the same antibody 
failed to detect the subunit in Western blotting and immunohistochemistry, even 
though it seemed to work well in three other studies probing myocardium, 
aortae and cerebral arteries (Sampson et al., 2004; Ploug et al., 2006; Philip-
Couderc et al., 2008). Interestingly, none of these studies mentioned which kind 
of transfer solution they used (see below).  
 
The third problem regarded the nature of channel subunits as membrane 
proteins, which often have anomalous migration during SDS-polyacrylamide gel 
electrophoresis (Rath et al., 2009). This often raises confusion as to the location 
of the bands. Zhou et al. (2007) generated specific anti-SUR2B antibody that 
revealed bands at 110 kD, and Philip-Couderc et al. (2008) obtained a similar 
result. Figure 3.8 shows the result of my Western blotting experiment using 
RASMC whole-cell protein (50 µg per lane). The SUR2B bands were located 
just below 130 kD mark, rather than the predicted size of 174 kD, raising doubts 
as to whether this protein band is indeed SUR2B, unless it undergoes 
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degradation. The signal intensity of these SUR2B bands was not measured, for 
the experiment was still being optimized when I had to leave UCL. 
 
 
 
 
Figure 3.8. Western blot of whole-cell protein from quiescent RASMC subject to 
lipopolysaccharide (LPS; 1 µg·ml-1) and interleukin (IL)-1β (10 ng·ml-1) for 48h. a) 
instead of the band appearing at the predicted 174-kD position, the bands were 
detected at ~110-kD. Fifty µg of protein were loaded. b) the blotted membrane was 
stained with Coomassie brilliant blue R for normalizing the amount of proteins loaded in 
each well. 
 
Control LPS + IL-1β  
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3.5. Discussion 
The results of experiments presented in this chapter showed that (i) RASMC 
subject to septic stimuli or ex vivo mesenteric arteries from 24h septic rats had 
an increased gene expression of KIR6.1 but not SUR2B subunit; (ii) the 
increased KIR6.1 gene expression in RASMC was prevented by pre-treatment 
with the NOS2 inhibitor, 1400W, suggesting expression was linked to NOS2 
induction; and (iii) while the increased KIR6.1 gene expression in mesenteric 
arteries was associated with an increase in Lev-stimulated channel activity, the 
aortae from the same rats had an increased channel activity which, in contrast, 
was not associated with gene induction. This suggested that channel kinetics 
may also be altered during sepsis. This latter finding raised doubts as to the 
extent to which abnormal KATP channel gene expression can contribute to the 
sepsis-induced vascular changes. 
 
The unparallel increase in vascular KATP subunit gene expression is not an 
uncommon finding. Rat embryonic heart-derived H9c2 cells subject to hypoxia 
(partial pressure 100 mmHg) or 17β-estradiol (100 nM) for 24h showed an 
increased SUR2A but not KIR6.2 gene expression (Crawford et al., 2003; Ren et 
al., 2003). In contrast, an increase in KIR6.x but not SUR2 gene expression was 
observed in the setting of ischaemia and chronic inflammation (Akao et al., 
1997; Sgard et al., 2000; Jin et al., 2004). In the absence of SUR gene 
induction, the increased KIR6.x gene expression may still lead to an increased 
channel activity, depending on the amount of SUR2B reserve in the cell (van 
Bever et al., 2004). Additionally synthesized KIR6.1 may be degraded (Crane 
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and Aguilar-Bryan, 2004) or participate in other physiological processes that 
remain to be defined, e.g. the modulation of intracellular Ca2+ handling and 
muscle contraction (Ng et al., 2010) 
 
NO regulates gene expression mostly through indirect mechanisms such as 
modulating transcriptional factors (e.g., NF-κB, AP-1), mRNA translation and 
stability, and processing of gene products (Bogdan, 2001a; Pfeilschifter et al., 
2001). Importantly, the proper functioning of the NF-κB signaling pathway 
seems to rely heavily on iNOS activity (Hierholzer et al., 1998; van't Hof et al., 
2000). This may explain why 1400W prevented KIR6.1 gene from being induced 
by LPS and IL-1β in RASMC, as Shi et al. (2010) reported that sepsis-induced 
KATP channel gene expression of KIR6.1 and SUR2B was driven by NF-κB. This 
study also demonstrated that actinomycin was able to inhibit the production of 
channel mRNA. It would have been helpful if the KATP channel activity was 
measured in cells subject to LPS and actinomycin: the absence of an increased 
channel activity in these cells would indicate the role of channel gene induction 
in augmenting channel activity, whereas channel hyperactivity signifies altered 
channel kinetics during sepsis. The author did show a temporal increase in 
channel activity in parallel with gene expression, suggesting channel kinetics 
probably remained unaltered in this model. 
 
An increase in basal 86Rb+ efflux in arteries from septic animals did not appear 
as expected. This may be due to the limited sensitivity of the assay to pick up 
small increases in the opening of the vascular KATP channel. But how much of a 
change in 86Rb+ efflux should be expected in this scenario? Suppose sepsis can 
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increase basal KATP channel activity by 50% (Shi et al., 2010), and the change 
the 86Rb+ efflux induced by 10 µM Lev represents a 5-fold increase in basal 
activity (Nelson and Quayle, 1995), it could be estimated that in the current 
experiment, the basal KATP channel activity is about 2.6% of 86Rb+ efflux in 
aortae and 1.3% in mesenteric arteries, and sepsis should increase the efflux 
by 1.3% in aortae and 0.6% in mesenteric arteries, respectively. Considering 
the standard deviation of 86Rb+ efflux measured in these vessels and the 
mortality of the current model (see 4.2), about 75 24h septic rats need to be set 
up to achieve a statistic power of 70% for the difference in the mesenteric artery 
to be significant. For the difference in the aorta, 29 rats need to be set up. Thus 
the 86Rb+ efflux experiment might be less ideal for demonstrating the change in 
basal KATP channel activity induced by sepsis. One unexpected finding was the 
decrease in Lev-stimulated 86Rb+ efflux in aortae from sham rats at 24h, 
indicating the presence of higher channel activity at 6h which later recovered. 
Such stimulation may have originated from the trauma of instrumentation, but 
this needs to be confirmed by comparing to the results using aortae from the 
naive rats. 
 
The major deficiencies for this part of the study are the inability to demonstrate 
an increase in channel protein production and surface expression in 
correspondence with channel gene induction. With suspicion to the specificity of 
the commercially available antibodies (Foster et al., 2008), I did not, however, 
seek to generate the antibody by myself or to obtain it from other researchers. 
Electrophysiological experiments were attempted by an experienced and skillful 
postdoctoral fellow in the host lab so as to measure the plasmalemmal channel 
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number in freshly isolated smooth muscle cells from ex vivo rat aortae, but 
difficulties were encountered and unfortunately the experiment could not be set 
up in time. 
 
In summary, KIR6.1, the pore-forming subunit of vascular KATP channel, was 
inducible by septic stimuli, but the regulatory SUR2B subunit was not. In 
cultured RASMC, increased KIR6.1 expression was associated with an increase 
in KATP channel function, and both phenomena were reversible by NOS2 
inhibition. Ex vivo aortae and mesenteric arteries from rats subject to faecal 
peritonitis for 24h showed an increase in Lev-stimulated KATP channel activity, 
but only mesenteric arteries had increased KIR6.1 expression. Ex vivo arteries 
had not an increase in basal KATP channel activity, possibly owing to the limited 
sensitivity of the 86Rb+ efflux experiment to detect its change as induced by 
sepsis. The increase in channel number inducible by sepsis may be limited by 
the SUR2B reserve in arterial smooth muscle cell. 
 
 103 
Chapter Four Characterization of the in vivo rat model of faecal 
peritonitis 
Chapter 4. Characterization of the in vivo rat model of faecal peritonitis 
 
4.1. Introduction 
In the KATP subunit gene expression experiments I saw a marked increase in 
KIR6.1 mRNA in rat aortic smooth muscle cell (RASMC) stimulated by 
lipopolysaccharide (LPS) and interleukin (IL)-1β for 48h, however I did not find 
this in ex vivo aortae taken from rats after 24h of faecal peritonitis. Although 
measurement at a later timepoint may have demonstrated induction of the 
KIR6.1 subunit in aortae, the rats were unlikely to extend much beyond 24h. The 
severity of this model had clearly changed since its original description (Brealey 
et al., 2004) where a 72h mortality of 40% was reported. Because of potential 
concerns of fluid overload, a revised model only used half the volume of fluid 
resuscitation (Barrett et al., 2007a) and achieved mortality rates of 32% at 24h, 
and 64% at 48h. In both these studies, haemodynamics, renal and liver 
function, and mortality were all assessed. I used the modified (lower) fluid 
regimen and further assessed the degree of tissue hypoperfusion and the levels 
of NO generated, as well as the animals’ pressor response to vasoactive 
therapy. The higher mortality I witnessed was common to other investigators 
within the lab at the time and suggests an altered phenotype of the rats in 
response to the fixed septic insult. Meanwhile, as part of another study running 
concurrently within the lab, rats were receiving a faecal peritonitis insult but 
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received no fluid resuscitation. I have collated data from these different models 
to assist with characterization. I gratefully acknowledge the assistance of Drs. 
Alex Dyson (arterial base excess and lactate levels in non-reserpinized sham 
and septic rats at 24h) and Zhen Wang (survival time and blood pressures of 
faecal peritonitis rats without fluid resuscitation). 
 
4.2. Faecal peritonitis model is a severe model of septic shock 
Using an identical design to the Barrett model with the modified fluid regimen, I 
found a 24h mortality of 48.2%. In the original study (Brealey et al., 2004), a 
scoring system was designed to grade disease severity according to the clinical 
presentations of these animals (Table 4.1). Results of the grading system 
correlated well with changes in MAP in septic rats at 24h, and the degree of  
 
Table 4.1. Severity scoring system of rats subject to faecal peritonitis. Table 
reproduced from Brealey et al. (2004). 
 Mild Moderate Severe 
Appearance Hunched 
Piloerection 
No bloating 
Hunched 
Marked piloerection 
Bloated abdomen 
Marked piloerection 
Markedly bloated 
abdomen 
Conjunctival 
injection 
Alertness Alert 
Occasional interest 
in environment 
Moves freely 
Depressed level of 
alertness 
Little interest in 
environment 
Moves with difficulty 
Markedly (or 
absent) depressed 
level of alertness 
No interest in 
environment 
No movement 
MAP >90 mmHg 75–90 mmHg <75 mmHg 
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kidney and liver dysfunction. However, surviving septic rats presented with  
different disease severity at 24h and 48h. Therefore, septic animals categorized 
to the same disease severity at different timepoints may actually represent 
distinct disease processes. 
 
In my project, 164 rats (mean weight, 308 ± 3 g) were successfully instrumented 
and made uneventful post-operative recoveries. Of the 148 animals, 68 (54 for 
6h; 15 for 24h) were used as sham-operative controls, while peritonitis was 
induced in 87 (66 for 6h; 29 for 24h). Control animals appeared outwardly 
normal throughout. The septic animals showed features of illness, including 
hunched posture, piloerection, and decreased movement and alertness from 
12h after faecal slurry injection. Mortality rates for septic rats at 6 and 24h was 
6.1% and 48.2%, respectively, and 0% in controls. Despite 24h septic rats had 
a high mortality rate that might be related to the excessive amount of faecal 
slurry injected, I did not alter the faecal slurry dose so as to ensure the targeted 
disease severity could be obtained at 6h. 
 
4.3. Severity of tissue hypoperfusion and levels of NO generation 
The levels of arterial base excess (negative values indicate a deficit) and 
plasma lactate were used as surrogate markers of tissue hypoperfusion. In the 
septic animals a metabolic acidosis was present as early as 6h while plasma 
lactate levels were elevated after 24h. Plasma nitrate/nitrite (NOx) levels were 
elevated at 6h and, in surviving septic animals, the levels remained high (Figure 
4.1). 
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Figure 4.1. Arterial base excess (a), plasma lactate (b) and nitrate/nitrite (NOx; c) 
levels of rats subject to faecal peritonitis for 6 and 24h. A negative value of base 
excess indicates a deficit. *p <0.05, **p <0.01 (two-way ANOVA with Bonferroni post-
hoc test). 
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4.4. Effect of fluid resuscitation 
An important feature of this model is the incorporation of intravenous fluid 
resuscitation. As sepsis can induce changes leading to reductions in effective 
circulatory volume, its repletion is essential in maintaining haemodynamic 
stability. Moreover, the hyperdynamic state that characterizes septic shock can 
be present only after volume repletion (Carroll and Snyder, 1982; Otero et al., 
2006). In clinical practice, fluid resuscitation is prioritized as the first line 
treatment for septic patients with haemodynamic instability (Hollenberg et al., 
2004). 
 
The importance of fluid resuscitation can be further demonstrated by the finding 
that none of the 24 rats subjected to faecal peritonitis who were not fluid 
resuscitated survived beyond 24h. Mean surviving time was 13.3 ± 1.0h, and 
eleven (46%) died within 10h. Five hours after intraperitoneal injection of faecal 
slurry, these rats developed a more severe metabolic acidosis (arterial base 
excess -10.4 ± 2.9 mM, n = 7) than their fluid-resuscitated counterparts (p = 
0.016). Of note, none of the 24 rats developed hypotension at 5h and three 
quarters manifested no hypotension (defined as drops in mean arterial pressure 
[MAP] of >20%) until the last hour before death. This likely reflects the ongoing 
ability of these awake animals to mount a vasopressor response, despite the 
decreased vascular reactivity to exogenous catecholamines. 
 
A reasonable question of the model to address is whether the volume of fluid 
administered (10 ml·kg-1·h-1 for 22 h) was adequate, insufficient or even 
excessive. Indeed, excessive fluid can also lead to adverse outcomes (Brandt 
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et al., 2009). At laparotomy, all the septic rats showed evidence of peritoneal 
inflammation that varied from small-volume ascites and mild bowel oedema to 
gross bowel distension with purulent ascites and multiple adhesions. In 
contrast, none of the sham rats had ascites. Importantly, many septic rats 
developed large-volume ascites that amounted up to 8 ml at 6h. This could 
have counterbalanced a large part of the fluid administered. Concurrent 
echocardiographic studies in the lab using this rat model by Dr. Alain Rudiger 
revealed this fluid regimen to be acceptable though severity, as reflected by the 
degree of ascites, clearly varied markedly between animals. For simplicity and 
constancy of approach, I gave a fixed fluid regimen to all animals and no 
individual titration depended on the degree of sepsis-induced severity. Whether 
this may have contributed to any confounding of my results requires further 
study. 
 
4.5. Baseline blood pressure and response to norepinephrine 
The septic rats had an elevated MAP at 6h post-slurry whereas this had fallen 
by 24h (Figure 4.2b). This increase in MAP at 6h is likely to have resulted from 
increased sympathetic tone as septic rats developed tachycardia, with their 
heart rates increasing from 366 ± 12 beats per min (bpm) at 0h, to 519 ± 14 
bpm at 6h (n = 8, p <0.01). At 24h, the septic rats remained tachycardic (520 ± 
34 bpm; n = 4). By comparison, the heart rates of sham rats at 0 and 6h were 
329 ± 14 and 344 ± 9 bpm, respectively (n = 6, p = NS). Irrespective of their 
blood pressure, septic rats had an attenuated pressor response to NE at both 
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6h and 24h timepoints (Figure 4.3). Thus, vascular hyporeactivity preceded 
hypotension and was already present at 6h.  
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Figure 4.2. Baseline mean arterial pressure (MAP) at 0, 6 and 24h in sham (n = 50 
in 6h group and 11 in 24h group) and septic (n = 57 in 6h group and 19 in 24h 
group) rats with fecal peritonitis. Dotted lines represent the 24h group. **p <0.01; †p 
<0.05 compared to sham rats at the same timepoint (two-way ANOVA repeated 
measures with Bonferroni post-hoc test). 
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Figure 4.3. Representative blood pressure (MAP) traces of (a) sham-operated and 
(b) septic rats pre- and post-administration of norepinephrine (NE; 0.5 µg·kg-
1·min-1 i.v.) at the 24h timepoint. The pressor effect is shown in sham and septic 
rats at (c) 6h and (d) 24h. Boxes represent median and interquartile range (n = 5). **p 
<0.01 compared to baseline pressure; †p <0.05, ††p <0.01 compared to sham animals; 
‡‡p <0.01 compared to 6h (two-way ANOVA repeated measures with Bonferroni post-
hoc test). 
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4.6. Effects of NOS inhibition 
Since excessive generation of NO is a major factor that contributes to sepsis-
induced vascular changes, I assessed whether these could be reversed by 
inhibiting NO production. I chose to use SEITU as it not only inhibits NOS2 
(inducible) but also inhibits NOS3 (endothelial) (Boer et al., 2000). The latter 
isoform may be activated in early sepsis and also contribute to vascular 
hyporeactivity (Thiemermann, 1997). Given septic rats had a higher level of NO 
production (see Figure 4.1), I expected SEITU should have had a stronger 
pressor effect in these animals. However, my findings did not confirm this 
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Figure 4.4. Mean arterial pressures (MAP) of nonreserpinized septic rats before 
and after administration of S-ethylisothiourea (SEITU; 0.1 mg·kg-1·min-1 i.v.), with 
and without norepinephrine (NE; 0.5 µg·kg-1·min-1 i.v.) at 6 (a) and 24h (b). Boxes 
represent median and interquartile range (n = 5). *p <0.05, **p <0.01 compared to 
baseline pressure; ††p <0.01 compared to pressure after SEITU administration; ‡p 
<0.05, ‡p <0.01 compared to sham animals at the same timepoint; §p <0.05 compared 
to pressure at 6h timepoint (two-way ANOVA repeated measures with Bonferroni post-
hoc test). 
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 (Figure 4.4). At 6h, when blood pressures were being maintained in the septic 
animals, the pressor response to SEITU was similar in both sham and septic 
rats but the subsequent administration of NE still produced a significantly 
greater response in the sham animals. At 24h, however, when blood pressures 
in the septic animals were lower, there was a significant rise in BP with SEITU 
over and above that seen in the sham animals. However, the subsequent 
response to NE was blunted in both sham and septic animals (Figure 4.4b). 
 
4.7. Discussion 
The data presented in this chapter demonstrated that at 6h post-faecal slurry 
injection septic rats had raised blood pressure but an attenuated pressor 
response to NE. The pressor response of 6h septic rats to SEITU was less 
prominent, contradicting with their augmented NO synthesis in vivo. At 24h 
post-faecal slurry injection septic rats developed hypotension and vascular 
hyporeactivity to NE. Septic rats with faecal peritonitis could maintain their blood 
pressure till moribund, even in the absence of intravenous fluid resuscitation. 
This could mean that the blood pressure-maintaining mechanisms had a high 
feedback gain (Figure 1.1), unlike septic patients who often develop 
hypotension because the body cannot fully compensate the vascular changes. 
However, this could also mean that septic rats were less tolerable to 
hypotension and fell dead soon after its development. Either way, in this model 
the blood pressure may not correlate well with disease severity, an observation 
that was seldom recognized before. 
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The concurrent presence of hypertension and vascular hyporeactivity to NE in 
the 6h septic rat was particularly confusing as to whether this model actually 
reproduces sepsis-induced vascular changes. The fact that the rats in the 
current model were not anaesthetized may explain the disparity, as anaesthesia 
may pose inhibitory effect on the sympathetic efferent nerve activity (Seagard et 
al., 1984) and the baroreceptor reflex (Saeki et al., 1996). How would the septic 
rat’s pressor response to NE and SEITU be affected by a ‘more intact’ state of 
compensatory mechanisms? One scenario that I speculate might be that if the 
septic rat had already relied on reflex sympathetic stimulation to maintain blood 
pressure, the i.v. infusion of NE or/and SEITU would have partially relieved the 
reflex stimulation, resulting in a decrease in background sympathetic tone while 
the animal’s blood pressure remained the same, giving rise to an ‘attenuated’ 
pressor effect of these agents. The sympathetic nerve activity of the 6h septic 
rats before and after administration of NE and SEITU should be measured so 
as to understand whether the background sympathetic tone is decreased. If 
yes, then the model may risk underestimating the pressor effect of a vasoactive 
agent. To my knowledge, this observation of the concurrent presence of 
hypertension and vascular hyporeactivity in septic rats has never been 
described before. 
 
In this model, the host lab previously showed that the 24h plasma level of NE 
was four-fold higher in septic rats compared to sham-operated controls (Barrett 
et al., 2007a). The increased sympathetic tone may be related to a maintained 
response to ongoing inflammation system (Zhou et al., 1991; Hahn et al., 1995) 
plus also any associated discomfort (the animals did not appear to be in 
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obvious pain) and/or any uncorrected hypovolaemia. Moreover, sepsis may 
pose a direct effect on sympathetic tone. Endotoxin can stimulate sympathetic 
nerves directly in rats (Zhou et al., 1991) though in healthy humans it may 
conversely inhibit them (Sayk et al., 2008). Pancoto et al. (2008) reported an 
increase in autonomic centre neuronal apoptosis in some patients dying from 
septic shock. The ability of the autonomic nervous system to modulate tone in 
the heart and blood vessels may also become impaired (Annane et al., 1999). 
 
Sepsis initially stimulates NOS3 activity and later induces expression of NOS2, 
both of which contribute to the excessive amounts of NO that induces 
vasorelaxation and vasoplegia (Thiemermann, 1997). The results seen with this 
current model did reveal a stronger pressor response to the non-selective NOS 
inhibitor, SEITU in septic rats at 24h; however, NOS inhibition failed to 
normalize the blood pressure in these animals. This suggests the presence of 
mechanisms other than NO that contribute to hypotension. Potential other 
mediators include prostacyclin (Zardi et al., 2007), calcitonin gene-related 
peptide (Joyce et al., 1990; Tang et al., 1997), and increase in Na+-K+ pump 
activity (Chen et al., 2003). The accentuated pressor response to SEITU seen 
in sham rats at 6h may have resulted from anaesthesia and the instrumentation 
procedure that stimulated NOS activity in these animals. The dose of SEITU 
used already lowered cardiac output (Dyson A, unpublished observations), and 
rats seemed intolerable to higher doses of this agent (data not shown). The 
decrease in cardiac output may be the result of an increased cardiac afterload, 
a decreased coronary blood flow, or/and a decrease in reflex sympathetic 
stimulation as was discussed earlier. This decrease in cardiac output may 
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underlie the attenuated pressor response to SEITU in septic rats. Likewise, 
SEITU did not fully reverse the attenuated pressor response to NE in septic 
rats, either at the 6h or 24h timepoints. The vasoplegic effect may originate 
from NO stored in vivo as S-nitrosothiol and nitrite (Rodriguez et al., 2003; 
Dejam et al., 2005). Consistent with this notion, (da Silva-Santos et al., 2002) 
showed that rats exposed to LPS for 24h had an attenuated pressor response 
to phenylephrine, which could not be reversed by L-NAME, but could be 
reversed by ODQ. They suggested that sGC activity contributed to the 
vasoplegia, and that this was not stimulated by newly synthesized NO. 
 
In summary, the faecal peritonitis model used in this study was a severe model 
of sepsis. How this affects vascular reactivity requires further investigation. The 
septic animals were clinically unwell and developed signs of organ dysfunction 
yet I did not witness the expected greater effect from NOS inhibition, despite 
evidence of increased NO production. The relative maintenance in blood 
pressure occurred despite marked vascular hyporeactivity to NE. This finding 
implies that the rat’s blood pressure-maintaining mechanisms has a high 
feedback gain. 
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Chapter Five Changes in blood pressure induced by KATP channel 
modulation 
Chapter 5. Changes in blood pressure induced by KATP channel 
modulation 
5.1. Introduction 
As septic shock is characterized by arterial and venous vasodilatation, and the 
vascular KATP channel is an important regulator of vascular tone, it is 
reasonable to assume that vascular KATP channels may be stimulated during 
sepsis to induce arterial vasodilatation. Pharmacological agents that cause KATP 
channel opening can indeed induce hypotension that could be reversed by the 
KATP channel inhibitor glibenclamide (Singer et al., 2005). However, the same 
drug was not able to reduce the dose of NE or shorten the duration of its usage 
in septic shock patients (Warrillow et al., 2006). This may be related to an 
insufficient dose to block the ion-conducting subunit of the KATP channel, which 
requires a higher concentration than is likely ever to be given to patients 
(Buckley et al., 2006). PNU-37883A, a vascular KATP channel inhibitor acting 
primarily on the pore-forming KIR6.1 subunit, was able to reverse LPS-induced 
vascular hyporeactivity to NE in ex vivo rat mesenteric arteries, while 
glibenclamide was not (O'Brien et al., 2005). However, when PNU-37883A was 
administered to anaesthetized rats with endotoxic shock, the pressor response 
in septic was not as marked as in sham rats (O'Brien et al., 2009), possibly 
suggesting that sepsis may alter the channel in such a way as to make channel 
inhibitors less able to bind, irrespective of whether they bind to SUR or KIR6.x 
subunits (Wilson and Clapp, 2002). The importance of the vascular KATP 
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channels in causing vasodilatation and vascular hyporeactivity in sepsis thus 
remains difficult to tease out. The results from Kane et al. (2006) would support 
the notion that these channels do indeed contribute to the cardiovascular 
collapse in sepsis. They showed in a short term model of endotoxic shock that 
KIR6.1 knockout (KO) mice did not become hypotensive in the presence of LPS, 
whereas they did in wild-type mice. However, surprisingly, endotoxic KO mice 
all died within 24h, whereas mortality in wild-type mice could be improved by 
the administration of the KATP channel opener pinacidil. They claimed that 
coronary vasospasm was the cause of death in the endotoxic KIR6.1-KO mice 
due to the lack of functioning KATP channels in the coronary vascular bed (Miki 
et al., 2002). Verapamil, a L-type Ca2+ channel blocker, dilated their coronary 
arteries and rescued some animals from dying. These results suggest that the 
vascular KATP channel participates in the modulation of vascular tone in health 
as well as disease states. At least in mice, the strategy of inhibiting vascular 
KATP channels to reverse septic shock is questionable, as it may do more harm 
than good. 
 
After seeing the results of the in vivo pharmacology experiments involving PNU-
37883A in anaesthetized rats (O'Brien et al., 2009), I wondered whether their 
anaesthetized state, or the use of the anaesthetic agent isoflurane, which has 
KATP channel opening effects of its own (Iida et al., 1998; Tanaka et al., 2007), 
could have confounded the interpretation of results. I thus decided to test the 
pressor effect of PNU-37883A in conscious rats. Instead of the endotoxaemic 
model I used the faecal peritonitis model, thinking the latter more resembled 
real disease conditions, and presumably the resultant systemic inflammation 
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would be similar. Admittedly this replacement of the model did not entirely 
follow the scientific principles. Nevertheless, sham-operated rats still presented 
with a pressor response to PNU-37883A more prominent than septic rats 
irrespective of anaesthesia and the means to induce sepsis. 
 
5.2. Effects of KATP channel modulation 
PNU-37883A elevated mean arterial pressure (MAP) by approximately 25 
mmHg in awake sham rats at both 6h and 24h timepoints (Figure 5.1a, c, d). 
This rise is comparable to that seen with PNU-37883A in anaesthetized rats 
(O'Brien et al., 2009) and in KIR6.1-KO compared with wild type mice (Kane et 
al., 2006). As with NOS inhibition, I speculated that PNU-37883A should have a 
more potent pressor effect in septic rats who would supposedly have higher 
levels of vascular KATP channel activation. As with the findings in anaesthetized 
rats, PNU-37883A (at the dose used) had a less prominent pressor effect at 
both 6h and 24h in the septic animals compared to the sham-operated controls. 
Changes in MAP induced by PNU-37883A in septic rats at 6h and 24h were not 
significantly different (n = 5, p = NS), being 7.6 ± 1.4 mmHg and 11.2 ± 1.8 
mmHg, respectively. As with the NOS inhibitor SEITU, PNU-37883A also failed 
to reverse the attenuated pressor response of NE in the septic animals (Figure 
5.1).  
 
As this could potentially be related to an insufficient dose of PNU-37883A to 
reverse the hyperactivity of the channel, I then constructed dose-response 
curves of PNU-37883A in sham and septic rats at the 6h timepoint. I found that  
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Figure 5.1. Representative blood pressure (MAP) traces from (a) sham-operated 
and (b) septic rats pre- and post-administration of PNU-37883A (PNU; 1.5 mg·kg-1 
and 1.0 mg·kg-1·h-1 i.v.) and norepinephrine (NE; 0.5 µg·kg-1·min-1 i.v.), at the 6h 
timepoint. Subgroup data are shown pre- and post-administration of PNU-37883A 
± NE at (c) 6h and (d) 24h. Boxes represent median and interquartile range (n = 5). *p 
<0.05, **p <0.01 compared to baseline MAP; ††p <0.01 compared to MAP post-PNU 
administration; ‡p <0.05, ‡‡p <0.01 compared to sham-operated animals at the same 
timepoint; §§p <0.01 compared to MAP at 6h (two-way ANOVA repeated measures with 
Bonferroni post-hoc test).  
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the dose used in the current study was already near the plateau of its maximal 
effect (Figure 5.2). Interestingly, the EC50 of PNU-37883A in sham and septic 
rats was not significantly different (–logEC50 = 0.51 ± 0.34 for sham, and 0.61 ± 
0.57 for septic; n = 4). 
 
As reasoned in 3.2.4 and 3.3.2, septic rats should have an accentuated effect to 
levcromakalim (Lev) if either KATP channel genes were induced, leading to more 
channels in the plasma membrane, or if channel opening was potentiated by 
interaction with channel modulators (Kessler et al., 1997). In both sham and 
septic animals, Lev increased vascular KATP channel opening, thereby relaxing 
arteries and lowering the blood pressure. As predicted, septic rats showed a 
bigger fall in MAP to Lev at 6h (Figure 5.3c and Figure 5.4). Such potentiation 
was not seen at the 24h timepoint where the same drop in MAP occurred from 
a lower baseline (Figure 5.3b and d). Of note, the EC50 of Lev in sham and 
septic rats at 6 and 24h were not significantly different. The logEC50 in sham 
and septic rats were 2.1 ± 2.8 and 1.3 ± 0.2 at 6h (n = 3), and 2.5 ± 5.5 and 1.7 
± 0.2 at 24h (n = 4) respectively. 
 
My underlying assumption was that sepsis had induced a profound hyperactivity 
of the vascular KATP channel that could not be reversed with PNU-37883A, so 
administration of Lev would also be impossible to reverse by the same dose of 
PNU-37883A. Thus, I tested the efficacy of PNU-37883A to inhibit Lev-induced 
vasorelaxation at the same dose used in Figure 5.1. I was proven wrong again 
as this agent could successfully reverse Lev-induced hypotension in septic rats 
(Figure 5.4). 
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Figure 5.2. Dose-response curves of the pressor response of sham-operated 
(sham) and faecal peritonitis (septic) rats to PNU-37883A (PNU), a vascular KATP 
channel inhibitor acting on KIR6.1 subunit. Rats were subject to faecal peritonitis for 
6h; all doses of PNU-37883A were given as 5-min infusions. n = 4. MAP = mean 
arterial pressure. 
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Figure 5.3. Dose-response curves assessing the effect of the vascular KATP 
channel opener levcromakalim (Lev) on mean arterial pressure (MAP, a and b) 
and its changes (∆MAP, c and d) in sham-operated and septic rats at 6h (a and c; 
n = 3) and 24h (b and d; n = 4). **p <0.01 compared to sham-operated controls (two-
way ANOVA repeated measures with Bonferroni post-hoc test). 
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Figure 5.4. Representative blood pressure (MAP) traces from (a) sham-operated 
and (b) septic rats pre- and post-administration of levcromakalim (Lev; 150 
µg·kg-1 i.v.) and PNU-37883A (PNU; 1.5 mg·kg-1 and 1.0 mg·kg-1·h-1 i.v.), at the 6h 
timepoint. Subgroup data are shown pre- and post-administration of Lev ± PNU-
37883A at (c) 6h. Boxes represent median and interquartile range (n = 4). **p <0.01 
compared to baseline pressure (two-way ANOVA repeated measures with Bonferroni 
post-hoc test). 
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Since septic rats presented with an elevated serum NOx level indicating 
excessive in vivo NO production, I wondered if this would cause the attenuation 
of the pressor response to PNU-37883A in these animals. The activity of the 
vascular KATP channel may be stimulated by NO, thus the inhibition of NOS 
might reduce this stimulation, resulting in a lower basal activity of the channel 
and an attenuated pressor response to PNU-37883A. In contrast, excessive NO 
may potentially make any increase in [Ca2+]i induced by vascular KATP channel 
inhibition insufficient to reverse the vascular change. In this case the inhibition 
of NOS activity may conversely increase the pressor effect of PNU-37883A. 
Which effect would predominate remains uncertain. 
 
Therefore at the 6h timepoint, I administered PNU-37883A to sham and septic 
rats on top of the continuous infusion of S-ethylisothiourea (SEITU). The 
resulting lesser increase in MAP in sham rats with PNU-37883A (Figure 5.5) 
suggests that vascular KATP channel activity may be stimulated by NOS3 activity 
in normal physiology. However, in septic rats the combination of SEITU and 
PNU-37883A infusion produced a greater pressor response than either agent 
alone, suggesting an additive effect of the two agents in our septic model, and 
the pressor effect of PNU-37883A seems less dependent on NOS activity. 
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Figure 5.5. Changes in mean arterial pressure (MAP) in 6h sham-operated and 
septic rats with faecal peritonitis at 6h as induced by PNU-37883A (PNU; 1.5 
mg·kg-1 and 1.0 mg·kg-1·h-1 i.v.), S-ethylisothiourea (SEITU; 0.1 mg·kg-1·min-1 i.v.), 
and co-administration of both drugs. Changes in MAP induced by PNU or SEITU 
alone were the same results shown in Figure 5.1c and Figure 4.4, respectively. 
 
 
5.3. Modulation of compensatory mechanisms 
It thus appeared that the dose of PNU-37883A was high enough to successfully 
reverse vasodilatation induced by a near-maximal dose of Lev, but in septic rats 
at either 6h or 24h timepoints its pressor effect was attenuated, and the KATP 
channel inhibitor could not reverse the vascular hyporeactivity to NE. The most 
straightforward conclusion is that the vascular KATP channel is not involved in 
the pathogenesis of septic shock in this model. Another possibility is that the 
mechanism induced by sepsis to open the channel could not be inhibited either 
by PNU-37883A or glibenclamide, i.e. sepsis may alter the pharmacological 
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behaviour of the vascular KATP channel. The third possibility is that the 
anaesthetics used in previous sepsis studies are major contributors to KATP 
channel activation as most anaesthetic agents are recognized modulators of 
vascular KATP channel activity (Kato et al., 2000; Kawano et al., 2004, 2005; 
Nakamura et al., 2007). To circumvent this, I explored the use of other 
anaesthetic agents that do not activate the channel to see whether a pressor 
effect of PNU-37883A could then be observed in septic animals. I decided to 
use midazolam as this has previously been reported to not alter vascular KATP 
channel activity in vitro (Nakamura et al., 2007). While midazolam is not actually 
an anaesthetic agent, the dose I selected has been reported to suppress the 
somatosympathetic reflex discharges in cats (Iida et al., 2007). Higher doses of 
midazolam was avoided to prevent vasodilatation (Shiraishi et al., 1997). 
 
Except for a near-significant accentuation of the pressor response to PNU-
37883A in sham rats, midazolam had no other effect on pressor responses 
(Figure 5.6). However, the results seemed to imply a potential effect of the 
underlying sympathetic tone on the vascular KATP channel activity: midazolam 
might have suppressed the sympathetic tone of sham rats and somehow 
rendered them ‘hyperactive’ to PNU-37883A; in contrast, septic rats with high 
sympathetic tone had an attenuated pressor response to this agent. As vascular 
KATP channels can be inhibited by phenylephrine (Bonev and Nelson, 1996), it is 
possible that high sympathetic tone also inhibits the channel in vivo, thus 
rendering septic rats unresponsive to PNU-37883A. I thus decided to remove 
this high sympathetic tone to see if the pressor response of septic rats to this 
agent could be accentuated. 
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Figure 5.6. Mean arterial pressure (MAP) of 6h sham-operated and septic (faecal 
peritonitis) rats treated with PNU-37883A (PNU; 1.5 mg·kg-1 and 1.0 mg·kg-1·h-1 
i.v.) and norepinephrine (NE; 0.5 µg·kg-1·min-1 i.v.), with or without an intravenous 
infusion of midazolam 0.2 mg⋅kg-1⋅h-1 (MDZ). Open and closed squares reproduce 
the same data as shown in Figure 5.1c. n = 5 per group for rats receiving midazolam 
infusion. 
 
 
5.3.1. Pentolinium unmasked the PNU-37883A pressor response in septic 
rats 
I used the autonomic ganglion blocker pentolinium to block sympathetic nerve 
output and thus investigated its effects in sham and septic rats at 6h (Figure 
5.7). Infusion of pentolinium caused an immediate drop in blood pressure as 
shown by the example in Figure 5.7a. The septic rats had a larger drop in MAP 
than the sham animals, probably resulting from a significantly higher baseline 
blood pressure compared to shams (p <0.05) indicative of the presence of a 
higher sympathetic tone (Figure 5.7b). Furthermore, PNU-37883A elevated 
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blood pressure in pentolinium-infused sham rats to the same level as that 
measured in sham rats before the addition of pentolinium (Figure 5.7b). 
 
The pressor response to PNU-37883A in the pentolinium-infused septic rats 
was, however, accentuated compared to that seen in animals not pre-treated 
with pentolinium (Figure 5.7), even though it was still smaller compared to sham 
rats (Figure 5.7b). When infused with the same dose of NE, both sham and 
septic rats pre-treated with pentolinium had an increase in MAP that was much 
larger than without pre-treatment, indicating successful sympathetic inhibition. 
Thus, sepsis-induced vasorelaxation and vasoplegia may have had less to do 
with increased vascular KATP channel because of its inhibition by sympathetic 
activation and could therefore explain why PNU-37883A showed no pressor 
effect in septic animals in this model. 
 
To clarify that the potentiated pressor response to PNU-37883A in septic rats 
was not simply related to a lower baseline blood pressure, I re-tested it in the 
presence of two vasodilators that are not thought to directly affect sympathetic 
tone, namely sodium nitroprusside (SNP) and hydralazine. Under these 
conditions, PNU-37883A produced a similar pressor response, thus confirming 
that the potentiated pressor response to PNU-37883A seen with pentolinium 
could not be achieved by simply lowering blood pressure to a similar degree 
with either SNP or hydralazine (Figure 5.7c). Of note, this manoeuvre did 
reduce the pressor response of PNU-37883A in sham rats. The reason for this 
was unclear but might reflect a reflex stimulation of the sympathetic tone in  
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Figure 5.7. a) A representative blood pressure (MAP) trace of a septic rat with 
faecal peritonitis before and after administration of pentolinium (2 mg·kg-1 
followed by mg·kg-1·h-1 i.v.), PNU-37883A (PNU; 1.5 mg·kg-1 and 1.0 mg·kg-1·h-1 
i.v.), and norepinephrine (NE; 0.5 µg·kg-1·min-1 i.v.), at the 6h timepoint; b) Effect 
of PNU-37883A ± NE on MAP in sham and septic rats at 6h, either pre-treated or 
not with pentolinium; c) changes in MAP induced by PNU-37883A in sham and 
septic rats at 6h, with or without pre-treatment with pentolinium, sodium 
nitroprusside (SNP; 50 µg·kg-1·min-1 i.v.), or hydralazine (300 µg·kg-1·min-1 i.v.). *p 
<0.05, **p <0.01 compared to baseline pressure; ††p <0.01 compared to the changes in 
pressure after pentolinium administration; ‡p <0.05 compared to sham animals at the 
same timepoint (two-way ANOVA repeated measures with Bonferroni post-hoc test). 
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these animals (Figure 5.7c). In the septic rats pentolinium was also able to 
augment the pressor response to SEITU (Figure 5.8a), and to improve 
subsequent responsiveness to PNU-37883A (Figure 5.8b). This implies that 
vascular KATP channel responsiveness may be restored following removal of 
sympathetic tone and NOS activity. Surprisingly in sham rats PNU-37883A had 
no pressor response in the presence of SEITU. 
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Figure 5.8. a) Effect of S-ethylisothiourea (SEITU; 0.1 mg·kg-1·min-1 i.v.) ± 
norepinephrine (NE; 0.5 µg·kg-1·min-1 i.v.) on mean arterial pressure (MAP) in 
sham and septic rats at 6h, either pre-treated or not with pentolinium; b) Effect of 
SEITU ± PNU-37883A (PNU; 1.5 mg·kg-1 and 1.0 mg·kg-1·h-1 i.v.) on MAP in 
pentolinium-infused sham and septic rats at 6h. 
 
 
5.3.2. Reserpinized rats 
To confirm the above findings that the vascular KATP channel is inhibited by the 
high sympathetic tone in the awake septic rats, I tested the effects of PNU-
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37883A in rats that had undergone chemical sympathectomy by subcutaneous 
injection of reserpine (Martínez-Olivares et al., 2006). 
 
A total of 22 rats (mean weight, 306 ± 5 g) were pre-treated with reserpine. Of 
these animals, eight were used as sham-operated controls, and 14 had 
peritonitis induced in them. Prior to induction of sepsis, these animals showed 
marked weight loss (∆56 ± 2 g; equivalent to 18.3% body weight loss) within 
48h. All the reserpinized animals were set up for 6h experiments. Sham-
operated rats presented with metabolic alkalosis (arterial base excess 4.1 ± 0.9 
mM, n = 6, p <0.05 vs. 6h non-reserpinized rats) and an elevated plasma 
lactate level (2.9 ± 0.3 mM, n = 5, p <0.05), whereas septic rats presented with 
a more severe metabolic acidosis (arterial base excess -8.6 ± 1.3 mM, n = 6, p 
<0.01) and higher in vivo NO production (plasma NOx 78.4 ± 13.9 µM, n = 5, p 
<0.01). Septic rats had a 6h mortality rate of 28.6% (p <0.01), whereas none of 
the sham died at this timepoint. 
 
All rats presented with a lower blood pressure at the time of faecal slurry 
injection (101.6 ± 2.7 mmHg for sham rats, n = 8, p <0.05 vs. non-reserpinized 
animals; 102.3 ± 4.2 mmHg for septic rats, n = 11, p <0.01). At the 6h timepoint, 
sham rats responded to fluid resuscitation and their blood pressure was 
elevated (112.8 ± 3.6 mmHg, p <0.01 vs. 0h), whereas septic rats remained 
hypotensive (105.2 ± 5.6 mmHg). 
 
I intended to demonstrate that septic reserpinized rats had an accentuated 
pressor response to PNU-37883A, which could support the notion that the high 
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sympathetic tone presented in sepsis inhibits vascular KATP channel activity in 
vivo. Unfortunately the results were not as predicted (Figure 5.9). This may be 
due to the unexpected effect of reserpine that rendered the animals 
‘dehydrated,’ evident indirectly by the marked weight loss and the presence of 
metabolic alkalosis in sham animals (Lecompte et al., 1978). Despite this, sham 
rats still had a potentiated pressor response to PNU-37883A, albeit not 
statistically significant (Figure 5.9b). Reserpine did improve responses to NE in 
septic rats (Figure 5.9a). This may be related to upregulation of adrenergic 
receptors or a reduction in desensitization induced by NE deprivation. 
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Figure 5.9. a) Changes in mean arterial pressure (MAP) in non-reserpinized 
(squares) and reserpinized (triangles) sham and septic rats induced by PNU-
37883A (PNU; 1.5 mg·kg-1 and 1.0 mg·kg-1·h-1 i.v.), with and without 
norepinephrine (NE; 0.5 µg·kg-1·min-1 i.v.). b) Changes in MAP induced by PNU-
37883A in sham and septic rats that received no pre-treatment, pre-treated with 
pentolinium, and pre-treated with reserpine. **p <0.01 compared to appropriate no 
pre-treatment groups; ††p <0.01 compared to septic rats pre-treated with pentolinium; 
‡p <0.05, ‡‡p <0.01 compared to sham rats under the same condition (two-way ANOVA 
repeated measures with Bonferroni post-hoc test). 
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5.4. Discussion 
Perhaps the most striking finding in this particular study was that the autonomic 
ganglion blocker, pentolinium, substantially enhanced the pressor response to 
PNU-37883A in the septic rats. This suggests that the high sympathetic tone 
presenting in sepsis can inhibit vascular KATP channel activity in vivo. This 
inhibition may originate from PKC blockade of KATP channel activity (Bonev and 
Nelson, 1996; Hayabuchi et al., 2001; Thorneloe et al., 2002) since vaso-
constrictor receptors coupled to Gq will increase PKC activity through the 
second messenger diacylglycerol. Increased calcineurin activity (Wilson et al., 
2000; Orie et al., 2009) resulting from an elevated [Ca2+]i will also inhibit the 
KATP channel. Consistent with this notion, intracellular Ca2+ has been reported 
to rise in arterial smooth muscle during sepsis (Song et al., 1993) and the host 
lab have also observed this in the faecal peritonitis model (Barrett et al., 
unpublished observations). 
 
Little attention has been drawn to changes in PKC activity during sepsis, 
perhaps because vascular KATP channel activity has always been deemed to be 
increased and the focus has, to date, fallen heavily on this aspect. Indeed, 
animals, ex vivo tissues or cultured primary cells made septic often present with 
accentuated responses to KCOs (Sorrentino et al., 1999; Chen et al., 2000; 
Wilson et al., 2000; Shi et al., 2010). However, only an increase in basal 
activity, not the stimulated activity, can cause the vascular changes. Although 
smooth muscle hyperpolarization has been observed in ex vivo arteries from 
septic rats (Chen et al., 2000; Farias et al., 2002; Wu et al., 2004; Kuo et al., 
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2009), importantly, these findings were made in tissues from which sympathetic 
neural input had been removed. 
 
In a similar manner, the vasodilatory nature of sepsis has been a main focus of 
attention. Many studies have examined the influence of excessive NO 
production, the degree of attenuation in the pressor response to NE and, in 
clinical investigations, the reduced level of systemic vascular resistance. 
However, such subjects are still likely to have a high sympathetic tone, and their 
vascular KATP channel may become inhibited. Intravenous infusion of dopamine 
or NE as a therapeutic effort to correct septic shock may pose further inhibitory 
effects. This may possibly explain the failure of vascular KATP channel blockers 
in human sepsis (Warrillow et al., 2006; Morelli et al., 2007). 
 
While septic rats seemed to have an accentuated hypotensive response to Lev 
at 6h, this effect curiously diminished at 24h. This is in directly contrast to the 
86Rb+ efflux experiment, which demonstrated an augmented response to Lev in 
arteries from 24h septic rats (Figure 3.7). This discrepancy may be attributed to 
the lower blood pressure in the 24h septic rats that prevented them from 
becoming further hypotensive, or other compensatory mechanisms intervened 
and rendered Lev less effective in opening the channel. For example, 
calcineurin may directly oppose the effect of PKA (Orie et al., 2009) and thereby 
prevent the response to Lev from being potentiated (Kessler et al., 1997). 
Anyhow, the major implication is that the in vivo activity of the vascular KATP 
channel is not in parallel with that measured in vitro, and may change with time 
and disease severity. 
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Another important finding in this present work was that the pressor effect of 
PNU-37883A in sham rats was dependent on NOS activity. When co-
administered with SEITU, the pressor effect of PNU-37883A was attenuated in 
non-reserpinized sham rats, and in reserpinized sham animals, it was even 
abolished by SEITU. NO derived from NOS3 may activate endothelial (Wang et 
al., 2007) and/or smooth muscle KATP channels. Septic rats, reserpinized or not, 
still showed some pressor responses to PNU-37883A. This suggests that the 
vascular KATP channel activity in septic rats was not solely dependent on NOS 
activity; other stimuli present in sepsis could also open the channel. NOS3 
activity was the NOS activity possibly inhibited by SEITU in sham rats. 
 
In sham rats pre-treated with SNP and hydralazine, the pressor effect of PNU-
37883A was attenuated. This could be attributed to a reflex increase in 
sympathetic tone that subsequent inhibited the channel. However, it is also 
conceivable that arteries in these animals were simply relaxed too profoundly to 
become responsive to PNU-37883A. To further clarify the notion that high 
sympathetic tone inhibits vascular KATP channel hyperactivity in vivo, I should 
either stimulate the sympathetic nervous system of the sham rats and 
demonstrate an attenuated the pressor response to PNU-37883A, or to remove 
the high sympathetic tone in the septic animals to restore the pressor effect of 
this agent. Therefore I tested the effect of PNU-37883A in rats receiving 
reserpine as a means of chemical sympathectomy. I did not use the α-
adrenergic receptor antagonist phentolamine as this inhibits the KATP channel 
(Russell et al., 1992; Ibbotson et al., 1993; Proks and Ashcroft, 1997). I did not 
either use the other α-adrenergic receptor antagonists (e.g. prazosin, phenoxy-
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benzamine) because my intention was to deplete their NE reserves from the 
sympathetic nerves, so that the difference in levels of sympathetic inhibition 
would be minimized, and a lack of accentuation in the pressor response to 
PNU-37883A would not be originated from an insufficient sympathetic blockade. 
I did not use the muscarinic cholinergic receptor antagonist (e.g. atropine) 
because most blood vessels do not have parasympathetic innervation (Guyton 
and Hall, 2006). That reserpinized rats seemed to develop volume depletion 
was totally unexpected, which might cause the under-estimation of the pressor 
effect of PNU-37883A and render me unable to prove my point. 
 
In summary, the activity of the vascular KATP channel may be inhibited by the 
high sympathetic tone present in sepsis. I hypothesise this would occur through 
induction of PKC and calcineurin activity, although time precluded me from 
directly testing this. This inhibition can be removed by the autonomic ganglion 
blocker, pentolinium that can unmask the pressor effect of PNU-37883A in 
septic rats. Although the same changes could not be reproduced in reserpinized 
septic rats, this may be possibly due to their greater degree of volume depletion; 
indeed, reserpinized sham rats had a larger pressor response to PNU-37883A. 
In sham rats, the pressor effect of PNU-37883A appears to depend on NOS 
activity. Evidence is lacking to support the involvement of BKCa channel activity 
in sepsis-induced vascular changes in this model. 
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Chapter Six  Summary and Discussion 
Chapter 6. Summary and Discussion 
 
6.1. Summary of results 
The initial aim of the current project was to demonstrate that sepsis would 
increase vascular KATP channel gene expression and this would contribute to 
channel hyperactivity and vasorelaxation. While rendering animals septic to 
demonstrate the presence of channel induction in vivo, I also sought to confirm 
the therapeutic efficacy of vascular KATP channel pore blockade to reverse 
sepsis-induced vasoplegia. Unexpectedly, septic rats had a profoundly 
attenuated pressor response to PNU-37883A, and this attenuation could be 
partially reversed by the autonomic ganglion blocker, pentolinium. Reserpinized 
sham rats, although markedly dehydrated, still seemed to have an accentuated 
pressor response to PNU-37883A, suggesting that the resting sympathetic tone 
can pose some inhibitory effect on the vascular KATP channel. Since septic 
patients and animals often have a high sympathetic tone, it may well be that 
during the course of disease their vascular KATP channels remain inhibited 
owing to the consequence of increased PKC activity, plus an increased 
calcineurin activity resulting from an elevated [Ca2+]i in arterial smooth muscle. 
In this respect, the vascular KATP channel may have less contribution to the 
sepsis-induced vascular changes. However, I cannot rule out the possibility that 
sepsis reduces the ability of agents like PNU-37883A to block the channel 
which may mask or under-estimate KATP channel involvement. 
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Regarding vascular KATP channel induction, I found a fourfold increase in KIR6.1 
subunit gene expression in mesenteric arteries from 24h septic rats, whereas in 
aortae the gene expression of KIR6.1 appeared unchanged. For SUR2B, there 
was a decrease in gene expression in aortae from septic rats at 6h, otherwise it 
remained unchanged throughout. The increase in KIR6.1 transcriptional 
expression may not correlate well with the concurrent change in KATP channel 
activity, as the number of the newly generated channels may be limited by the 
amount of SUR2B reserve in the arterial smooth muscle cell. Besides, aortae 
from 24h septic rats had an increase in levcromakalim-stimulated KATP channel 
activity, but no increase in channel gene expression, suggesting that other 
mechanisms such as alteration in channel kinetics might be involved. Even if 
the number of channels in the plasma membrane is indeed increased owing to 
sepsis-related gene expression, the channels are likely to be inhibited by the 
high sympathetic tone present in sepsis, thus posing a smaller effect on the 
vasculature. One concern might be when agents able to open the vascular KATP 
channel (e.g., isoflurane, KCOs, and cyclosporin) are administered to septic 
patients or animals, this may accentuated the hypotensive effect, thus 
potentially worsening their condition. Nevertheless, pinacidil, another KATP 
channel opener, appeared to improve the mortality of endotoxaemic mice (Kane 
et al., 2006). 
 
An additional finding is that the pressor effect of PNU-37883A was much 
attenuated in sham rats treated with SEITU, suggesting that physiological 
activity of the vascular KATP channel is dependent on NOS3 activity. This 
suggests that the activity of the channel in vivo may be higher than that 
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observed in in vitro preparations. Also in both the absence and presence of 
pentolinium, SEITU had a more profound pressor effect than PNU-37883A in 
both sham and septic rats. This suggests that NO may contribute to the 
regulation of vascular tone through multiple pathways in addition to vascular 
KATP channel stimulation. 
 
6.2. Discussion 
The vascular KATP channel can be activated by various vasodilating stimuli, 
many of which become elevated during sepsis. Since channel hyperactivity can 
lead to vasorelaxation that is pathognomonic of septic shock, it seems a 
reasonable conjecture that during sepsis the channel is activated. However, this 
notion is directly controverted by the experimental finding of an elevated [Ca2+]i 
in aortic smooth muscle from septic rats (Song et al., 1993; Barrett et al., 
unpublished observations), which would have the effect of inhibiting channel 
activity (Orie et al., 2009). This begs the question whether vascular KATP 
channel hyperactivity and the consequent inhibition of voltage-dependent Ca2+ 
channel (VDCC) can exist at the same time with an elevated [Ca2+]i in arterial 
smooth muscle? Moreover, does arterial smooth muscle actually present with 
membrane hyperpolarization and VDCC inhibition in sepsis?  
 
As discussed previously, the membrane hyperpolarization of vascular smooth 
muscle in response to septic stimuli (Chen et al., 2000; Farias et al., 2002; Wu 
et al., 2004; Kuo et al., 2009) was demonstrated in ex vivo tissues, to which the 
counteracting/depolarizing effect of sympathetic tone has been removed. 
 140 
Whether the measured Em could reflect its true level in vivo remains 
questionable. Regarding the activity of VDCC during sepsis, (Chen et al., 2010) 
found that aortae collected from caecal ligation and puncture (CLP) rats showed 
augmented response to the VDCC inhibitor nifedipine, which was reversible by 
L-NAME. This suggested NO activates VDCC in these animals, a result in 
contrast with the general idea that NO donors inhibit VDCC (Clapp and Gurney, 
1991; Carvajal et al., 2000). In contrast, peak L-type Ca2+ current density was 
reduced in cardiac myocytes isolated from a porcine model of hyperdynamic 
septic shock (Stengl et al., 2010). Thus whether the activity of VDCC in sepsis 
is suppressed or activated remains to be clarified. 
 
Whether the vascular KATP channel is inhibited in vivo by the high sympathetic 
tone? Sham rats rendered hypotensive with sodium nitroprusside and 
hydralazine showed an attenuated pressor response to PNU-37883A; in 
contrast, reserpinized sham rats showed an accentuated response as the 
inhibitory effect from the sympathetic output was removed. These findings 
almost represent a continual levels of inhibition that dependents on sympathetic 
tone. The pressor response of septic rats to PNU-37883A could also be partially 
unmasked by pentolinium, which induced a greater drop in MAP in these 
animals suggesting the presence of a higher sympathetic tone. This is the first 
time that the activity of vascular KATP channels has been reported to be related 
to the sympathetic tone in vivo. It also appears that the vascular KATP channel, 
stimulated by physiological activity of NOS3, has a basal activity higher than 
previously suggested. Thus the channel may assume a more important and 
active role in the physiological regulation of vascular tone. 
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High sympathetic tone may also exert other effects to attenuate pressure 
elevation from vascular KATP channel blockade. The background arterial smooth 
muscle Em should be more depolarized in septic rats with a higher sympathetic 
tone. Inhibition of the vascular KATP channel may further depolarize the muscle, 
but the resultant increase in Po of VDCC might be less prominent, as at this 
level of Em the increase in Po tends to be offset by channel inactivation and 
decrease in driving force (Nelson et al., 1990). Also, NE can directly stimulate 
VDCC (Nelson et al., 1990). This and the activation of VDCC induced by 
membrane depolarization, together with a functional impairment of sarco-
plasmic reticulum Ca2+-ATPase (Walia et al., 2003), contribute to elevated 
[Ca2+]i in arterial smooth muscle. Even so, the muscle remains relaxed, 
suggesting presence of Ca2+ desensitization which renders elevated [Ca2+]i less 
capable of increasing contractility, but a decrease in [Ca2+]i more capable of 
relaxing the muscle. Thus in septic rats, a higher [Ca2+]i and Ca2+ 
desensitization may render vascular KATP channel blockade less effective in 
mediating vasoconstriction. 
 
In this regard, it seems reasonable that SEITU can exert a more potentiated 
pressor effect than PNU-37883A in septic rats and as SEITU would decrease 
cGMP and is thereby able to reverse Ca2+ desensitization. In addition, SEITU 
can also contract the venous vasculature which augments cardiac preload, 
whereas PNU-37883A probably cannot because venous smooth muscle does 
not appear to express KATP channels (Li et al., 2003). However, an increase in 
cardiac preload should bring about an increased cardiac output, but SEITU was 
actually found to decrease cardiac output (Dyson A, unpublished observations) 
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like that observed with other NO inhibitors (Vincent et al., 2000). Thus it remains 
uncertain whether NOS blockade can actually augment cardiac preload. 
 
Indeed, the revelation of effects of sympathetic tone on vascular KATP channel 
activity is indebted to the high sympathetic tone of septic rats at 6h, which was 
accompanied by an elevated blood pressure. Even though septic rats 
developed hypotension at 24h, the sympathetic tone is likely to be high as these 
animals still were tachycardic. Whether rats have a higher sympathetic tone 
compared to humans, and whether this can explain the stronger inhibitory effect 
on vascular KATP channel, remains to be determined. Plasma concentration of 
NE is frequently used as a marker of sympathetic activity. NE in plasma 
represents that secreted from adrenal medullae and that spilled into circulation 
from the junctions between postsynaptic neurons and end effector organs. The 
spillover reflects not only NE release from nerve terminals but also reuptake 
processes (Kopin et al., 1998). Indeed, much of the overall sympathetic tone 
originates from basal secretion of epinephrine and NE from adrenal medullae, 
with quantities sufficient to maintain the blood pressure up to normal even if the 
direct sympathetic stimulation to the cardiovascular system is removed (Guyton 
and Hall, 2006). NE represents 20% of catecholamines secreted from adrenal 
medulla, and the normal resting rate of secretion is about 0.05 µg⋅kg-1⋅min-1 
(Guyton and Hall, 2006). The normal plasma concentration of NE in humans is 
around 300-400 pg⋅ml-1 (Dimsdale and Moss, 1980), which is similar to that of 
rats (Barrett et al., 2007a). Rats subject to faecal peritonitis had a plasma NE 
level of about 2,000 pg⋅ml-1 beyond 24h, but the level was only about 600 pg⋅ml-
1 at 4h, when septic rats already had elevated blood pressure (Barrett et al., 
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2007a). Patients with septic shock or severe sepsis had even higher levels of 
NE when presented to the emergency department (about 3,600 pg⋅ml-1 for 
severely septic patients, Lin et al., 2005). On this basis, severely septic patients 
also have a high sympathetic tone, and possibly even higher than rats. Not to 
mention the therapeutic use of NE and dopamine as a key component of clinical 
resuscitation and treatment of septic shock. The therapeutic doses of NE 
ranges from 0.05 to 1 µg⋅kg-1⋅min-1 i.v., but can escalate to 3 µg⋅kg-1⋅min-1 
(Hollenberg et al., 2004). Infusion of 2.5 nmol (0.4 µg)⋅kg-1⋅min-1 of NE 
increased the plasma NE level to about 11 ng⋅ml-1 (Hjemdahl et al., 1979). The 
plasma NE level of non-surviving patients sustaining severe trauma or 
postoperative complications could become as high as 10 ng⋅ml-1 with 
administration of exogenous catecholamines (Boldt et al., 1995). With such high 
levels of sympathetic stimulation, the vascular KATP channel will be profoundly 
inhibited, making the channel less likely to contribute to vasorelaxation. 
 
Also the effect of pentolinium to accentuate the pressor response of septic rats 
to PNU-37883A may result from its blockade of parasympathetic output, which 
may also be high in sepsis (Shoemaker et al., 2005). Parasympathetic tone, 
through the release of agents like acetylcholine could inhibit the vascular KATP 
channel through PKC activity (Bonev and Nelson, 1993b; Quinn et al., 2004). 
However, in the absence of direct innervation, how much acetylcholine could be 
delivered to the vascular smooth muscle and exert the KATP channel-inhibitory 
effect remains uncertain, meanwhile the NO generated by the endothelium as 
stimulated by acetylcholine may offset this inhibition. How parasympathetic 
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nerve activity modulates vascular KATP channels and vascular behaviour during 
sepsis remains to be investigated. 
 
Figure 6.1 shows a schematic representation of interactions between 
vasoactive stimuli, [Ca2+]i and vascular KATP channel activity during sepsis. 
Sepsis can stimulate both vasoconstricting and vasodilating mechanisms 
simultaneously. Each mechanism imposes their respective effects on the 
channel, and on intracellular Ca2+ mobilization and homeostasis. Calcineurin 
activity can be stimulated by high [Ca2+]i, which can impose an additional 
inhibition upon vascular KATP channel activity. 
 
Nevertheless, results from Kane et al. (2006) seem to point out why KIR6.1 
subunit gene would be induced during sepsis. To simply put, without this 
increase in gene expression, septic animals may have died of coronary spasm. 
In other words, this increase in KIR6.1 gene expression may serve as a 
protective mechanism against overt vasoconstriction induced by sympathetic 
hyperactivity. Again, it seems odd to utilize gene expression as a compensatory 
mechanism to functional derangement. Nevertheless, mice carrying null alleles 
of KIR6.1 became more susceptible to bacterial endotoxin in causing death, 
which seemed again attributable to an increased coronary vasoconstriction. 
Moreover, fruit flies being suppressed of the Abcc9 (SUR2) homolog by RNA-
mediated interference became more susceptible to flock house virus infection in 
lethality, again attributable to an intrinsic heart defect (Croker et al., 2007). 
Therefore, surviving from sepsis seems indeed dependent on the presence of 
functioning vascular KATP channels. 
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Figure 6.1. Interactions between vasoactive stimuli, [Ca2+]i and vascular KATP 
channel activity during sepsis. Vasoconstricting stimuli (e.g., norepinephrine [NE], 
angiotensin [AT] II and endothelin [ET]) increase [Ca2+]i through phospholipase C 
(PLC)-β activity. These stimuli also inhibit vascular KATP channels through protein 
kinase C (PKC) activity. Vasodilating stimuli (e.g., nitric oxide [NO], calcitonin gene-
related peptide [CGRP] and adenosine) decrease [Ca2+]i through cAMP-dependent 
protein kinase (PKA) and cGMP-dependent protein kinase (PKG) activity; they can also 
stimulate vascular KATP channels through the activities of these enzymes, or directly 
through NO which can also modulate autonomic neural control and reflexes. An 
elevated [Ca2+]i also activates calcineurin activity, which is inhibitory to vascular KATP 
channels. It is thus likely that the KATP channel activity in vivo is mostly inhibited rather 
than activated in sepsis, even though both vasoconstricting and vasodilating 
mechanisms simultaneously impose their respective effects on the channel. 
Administering channel inhibitors can be potentially dangerous, as any remaining KATP 
channel activity may help to prevent the occurrence of coronary vasospasm. 
Hypovolaemia will also affect blood pressure, and could also confound results if blood 
pressure is used as a marker of sepsis-induced vascular changes. 
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The small sample sizes of many experiments in this study can constitute two 
serious problems, one is the low statistic power of the test to differentiate the 
true difference, and the other the under-estimation of biological variability, i.e. a 
small standard deviation of a measurement in a small-sized sample raises 
doubts as to whether this sample is representative enough to demonstrate the 
variability of the measurement. Most of my results showed significant 
differences without being affected by the low statistic power, probably except for 
the basal 86Rb+ efflux at 24h (discussed in 3.5), the increase in blood pressure 
in sham rats receiving midazolam and PNU-37883A, and that in reserpinized 
sham rats receiving PNU-37883A. Even though the main results remain the 
same, this concern should have been avoided during the setup of the 
experiment. The biological variability of the model was actually greater than I 
predicted, despite these rats were rather homeogenous: young, healthy, and 
bred in a stable environment. For example, the standard deviation of blood 
pressure in 6h sham rats was 15 mmHg (n = 47). Thus a larger sample size can 
cover a wider range of biological variability and allow more accurate estimation 
of the population. 
 
The major limitation of this project is that the model and the means of 
measurements used were subsequently found to be substantially confounded. 
Rats in the faecal peritonitis model may have been confounded by intravascular 
volume depletion, and changes in blood pressure seems not the most 
appropriate means to measure sepsis-induced vasorelaxation/vasoplegia. 86Rb+ 
efflux experiments were performed on ex vivo arterial tissues devoid of 
sympathetic stimulation and NOS activity, and the experiment itself was not 
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sensitive enough to detect changes in basal vascular KATP channel activity. 
Reserpinized rats unexpectedly developed severe hypovolaemia that 
confounded the blood pressure and vascular reactivity to vasopressors, and 
Western blotting could not accurately reflect changes in channel numbers in the 
plasma membrane. I have no evidence that directly supports the notion that 
vascular KATP channel is inhibited by the high sympathetic tone present in septic 
animals, and I am not certain that if there exists arterial smooth muscle 
hyperpolarization exists in septic animals and is sensitive to PNU-37883A. 
 
6.3. Future investigations 
An important lesson learned from this project is that the exact physiological 
events that occur in vivo cannot be accurately and completely reproduced in 
vitro. This could potentially lead to misinterpretation of experimental results and 
misconception of disease processes. It is still not entirely clear whether arterial 
smooth muscle actually develops membrane depolarization or hyperpolarization 
during sepsis in vivo, whether vascular KATP channels are activated by NO or 
suppressed by PKC and calcineurin activity in vivo, and to which level and 
through which mechanisms can sympathetic nervous system be activated by 
sepsis in vivo. Moreover, all these conditions could be affected by disease, 
pathogen, host and temporal factors, which should also be addressed. (Chen 
and Rivers, 2001) already devised a method that allows measurement of 
arteriolar smooth muscle membrane potential and [Ca2+]i in vivo. I would love to 
see if septic animals actually develop glibenclamide- or PNU-37883A-sensitive 
hyperpolarization during early and prolonged sepsis, and if sympathetic 
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inhibition in septic rats or sympathetic stimulation in sham rats would alter these 
membrane potential changes and corresponding [Ca2+]i. Besides, I would also 
like to test some means that are capable of modulating PKC and calcineurin 
activity in vivo, so as to confirm the cause-effect relationship between the high 
sympathetic tone present in sepsis and the inhibition of vascular KATP channel 
activity. 
 
Nevertheless, what seems more important to me as a clinician is to find out 
what causes septic shock, and how can it be reversed. The use of 
catecholamines to reverse hypotension cannot be fully justified (Singer, 2007), 
whereas NOS blockade (Lopez et al., 2004) and vasopressin administration 
(Russell et al., 2008) have not yet been proven beneficial over and above what 
catecholamines can do. Septic shock features arterial and venous 
vasodilatation, but baroreflex intact dogs were capable of compensating the 
haemodynamic instability resulting from the diffuse arteriolar dilatation induced 
by dinitrophenol (Banet and Guyton, 1971). Is there a defect in baroreflex that 
deranges this compensation during sepsis? Moreover, decapitated and spinal 
cord-destroyed dogs could increase their cardiac output as much as baroreflex 
intact animals if their blood pressure could be maintained through intra-arterial 
transfusion, suggesting sufficient venous return is extremely important in 
maintaining cardiac output provided myocardial contractility remains normal. 
Sepsis can induce venodilatation and vascular leak that decrease venous 
return, and also cardiac dysfunction that decreases the heart’s ability to 
compensate for hypotension. Importantly, intravenous fluid resuscitation in this 
setting may become less efficient if venodilatation and consequent increase in 
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vascular compliance are not controlled. It seems to me that these factors are 
important in causing/contributing to septic shock but are seldom addressed. I 
would like to further explore the change in venous vasculature and baroreflex 
that occurs during sepsis, its underlying mechanism, and the consequent 
alterations in haemodynamics and impact in disease outcomes.   
 
6.4. Concluding remarks 
The results of the study have highlighted the complexity of pathophysiology of 
septic shock, and the profound effect of sympathetic hyperactivity that poses on 
vascular smooth muscle. Intracellular Ca2+ handling in arterial smooth muscle 
can be affected by several mechanisms, and with disease progression and 
incremental metabolic burdens, derangements in individual mechanisms can 
vary in degree, rendering efficacy of rescue measures variable and 
inconsistent. In vivo models may not be suitable for dissecting out the effect of 
individual mechanisms; however, findings from in vitro studies may always need 
to be validated in an in vivo model that essentially reproduce clinical disease 
state and pathophysiology. The complexity of pathophysiology of septic shock 
should not be underestimated, and further studies are required to first define 
which characteristics amongst septic shock patients are more consistently 
present and significant that need to be reproduced in animal models. Equally 
important is the nature of the animal model itself: would any particular 
behaviour of the model confound the result? 
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The exploration of vascular KATP channel during sepsis was based on the 
thinking that the channel is an important regulator of vascular tone, and the 
channel can be inhibited by glibenclamide, an oral hypoglycaemic agent that 
has long been used clinically to treat type II diabetes mellitus. Although the 
rationale that the channel activated by NO facilitates vasodilatation during 
sepsis seems absolutely sensible, an equally important reason may be the 
readily availability of the therapeutic agent. Indeed, glibenclamide was used 
clinically to reverse haemodynamic instability induced by agents that 
pharmacologically open the channel (Singer et al., 2005), a result that was 
extremely persuasive and encouraging. It is apparent now that during sepsis 
the vascular KATP channel may or may not be activated, and glibenclamide no 
longer the ‘magic bullet’ that is able to attract people’s attention. Perhaps it 
would be prudent to look back to the molecular events of intracellular Ca2+ 
handling in more detail during sepsis, and to first determine the relationship 
between VDCC activity and arterial smooth muscle Em in the presence of high 
sympathetic tone and cGMP/PKG activity, before focusing on vascular KATP 
channels as a potential therapeutic target for septic shock. 
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